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ABSTRACT
REGULATING GENE EXPRESSION WITH LIGHT-ACTIVATED
OLIGONUCLEOTIDES
Julianne C. Griepenburg
Ivan J. Dmochowski

The work in this thesis identifies new photochemical approaches to gain high
spatiotemporal control over molecular structure and function, for broad applications in
materials and biological science. "Caged" compounds provide a method for temporarily
blocking function until acted upon by an external trigger, typically near-UV light. To
enable multiplexing studies, three new biomolecular caging strategies were developed
that can be activated with various wavelengths of near-UV or visible light. The first
method, an oligonucleotide hairpin structure incorporating one or two nitrobenzyl
photolinkers, was applied to a miRNA antagomir and used to “turn off” let-7 miRNA in
zebrafish embryos with 365 nm light. To achieve bidirectional control over miRNA, a
circular construct was designed for the ability to “turn on” the release of exogenous
miRNA into zebrafish embryos with 365 nm light. A second oligonucleotide caging
method, using a ruthenium-based photolinker (RuBEP), was designed to extend
photoactivation to the visible spectrum, with additional potential for two-photon
activation. RuBEP was used to cage antisense morpholinos through circularization via a
Cu(I)-mediated [3+2] Huisgen cycloaddition reaction. RuBEP-caged morpholinos were
photoactivated to “turn on” antisense activity and successfully knocked down zebrafish
iv

chd and ntl genes with 450 nm light, with limited background activity prior to irradiation.
A third method of caging was based on encapsulation within photoresponsive nanopolymersomes. Self-assembly of nano-polymersomes was optimized to generate visiblelight-responsive vesicles that incorporate a porphyrin dimer in the hydrophobic
membrane. These nanovesicles were shown to encapsulate a variety of cargo, including
25mer oligonucleotides, a small molecule fluorescent dye, and two biologically relevant
metal ions, Zn2+ and Ca2+. The photoresponsiveness of the system was modulated with
light wavelength, irradiation time, and the presence of dextran in the aqueous core.
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Chapter 1

Introduction to light-activation

1

I. "Uncaging" with light
The understanding of complex biological systems is advanced by tools that can
help manipulate structure, function, and or localization of molecules with high spatial and
temporal resolution. One strategy is to put an active compound under the control of a
conditional trigger. This concept of blocking a compound's biological activity until acted
on by an internal or external stimulus was termed "caging" in 1978 by Kaplan et. al. with
the photolytic release of adenosine 5'-triphosphate.1 Light-activation dates back to 1943,
however, with the example of azobenzene modified amino acids.2 Although the term
"caged" is now widely used in biochemistry, it is somewhat of a misnomer because most
caging strategies involve the use of one or more small photoactive moieties rather than
true molecular confinement.
Light in the UV to near IR (NIR) window is a commonly used external stimulus
for the activation of caged molecules as it can be very easily manipulated both temporally
and spatially. Spatial control depends on the irradiation source and activation wavelength,
but generally, confocal laser scanning microscopy (CLSM) and two-photon microscopy
provide excellent and well established spatial resolution with the ability to irradiate and
image simultaneously. Two-photon microscopy achieves high spatial resolution, with the
ability to control light in three dimensions down to the sub-cellular level and femtoliter
volumes.3,4 Although UV light has been commonly used for uncaging due to the broad
availability of UV-active caging groups5, uncaging with longer wavelengths of light has
many potential benefits. Absorption and scattering decrease with increasing wavelength,
2

as scattering has a λ-4 dependence on wavelength. Visible light is far less damaging to
cells than UV light6, and has the potential to penetrate biological systems up to 1 cm.7
This makes visible light activation feasible for small biological model systems and cells.
However, when transitioning to larger biological systems, significantly higher depth
penetration is necessary. The NIR window (700 - 900 nm) has a very low absorption
coefficient in biological tissue, and combined with low levels of scattering, NIR light has
the potential to penetrate tissue to depths of several centimeters.7 Above 900 nm, this is
hindered by strong water absorption.
It is important to expand the currently available caging toolkit to include a
broader range of biologically active molecules that can be controlled light. Specifically,
there is a need to be able to cage molecules ranging from small metal ions to large
proteins and plasmids. Additionally, it is of equal importance to expand the wavelengths
that can be used for uncaging. Several examples exist in the literature for caging moieties
that can be activated with UV light, but fewer exist for longer wavelength light in the
visible and near-IR region. Ideally, the future will hold a vast library of caged
biomolecules that can be activated with high spatiotemporal resolution at different
wavelengths of light spanning the UV, visible and near-IR spectrum.
This introduction will focus on literature precedent for three types of caging
relevant to the work presented in this thesis: 1) The commonly used UV-active moieties
and their applications in caging short oligonucleotides, 2) Visible and two-photon light
activated ruthenium complexes, and 3) Light-responsive polymersomes as nanocarriers.
3

II. Common caging groups
Three photoresponsive caging groups that have been commonly used for
biological applications are nitrobenzyl, coumarin, and azobenzene moieties, shown in
Figures 1-1, 1-2, and 1-3. These caging groups and their derivatives have received
attention for their ability to be incorporated site-specifically into biomolecules to control
structure and function with UV light.
The most commonly used caging group8, and the caging group used most
frequently in our laboratory is the nitrobenzyl group, shown in Figure 1-1. The orthonitrobenzyl has been widely used as a synthetic protecting group since initial reports in
1970.9,10 Ortho-nitrobenzyl is photoactive at 365 nm, but the wavelength can be tuned by
adding substituents. Common derivatives of 2-nitrobenzyl are the 4,5-dimethoxy analog
(DMNB), 1-(2-nitrophenyl)ethyl (NPE) and 4,5-dimethoxy analog (DMNPE) and αcarboxy analog (CNB) which range in activation wavelength from 260 nm to 365 nm.11
These analogs provide benefits and drawbacks, for example, CNB has increased
hydrophilicity due to the carboxy groups, but activates at shorter wavelengths (maximum
at 260 nm).12 DMNPE and DMNB activate at longer wavelengths (maximum at 355
nm), but photolysis rates and quantum yields are typically much lower than for CNB.
Recently, styryl-2-nitrobenzyl (SNB) moieties were presented to extend conjugation and
red-shift activation wavelengths to 370 nm, allowing tail-end activation up to 450 nm.13
The nitrobenzyl moiety has become so widely used for photocontrol over
oligonucleotides, that a phosphoramidite was made that can be directly incorporated into
4

solid-phase synthesis,14,15 and is now commercially available through Glen Research
(Sterling, VA).
Initial literature on coumarin protecting groups dates back to 1984 with the report
on 7-methoxycoumarin-4-ylmethyl (MCM) esters by Givens et al.16 Irradiation of
coumarin results in the release of the protected carboxylic acid and formation of the
corresponding hydroxymethyl coumarin. Typical MCM esters have activation
wavelengths in the UV (340 - 360 nm) range, but the spectral range of irradiation can be
altered with the addition of substituents, which can also change the hydrophilicity and
quantum yield of photolysis. Brominated 7-hydroxycoumarin-4-ylmethyl esters (Bhc) is a
coumarin derivative reported by Furuta et al. that has been modified to push the
activation wavelength to 365 nm. Additionally,

the extended conjugation and high

extinction coefficient for π-π* transitions makes Bhc two-photon active with a cross
section of 1 GM.17 This two-photon active coumarin has been applied to the design and
synthesis of a caged glutamate and used to resolve three-dimensional maps of neuron
glutamate sensitivity in intact mouse brain slices.17 Structures of coumarin (MCM ester)
and derivative Bhc are shown in Figure 1-2. Recently, coumarin derivatives have been
synthesized for photoactivation with visible light. Variations of (coumarin-4yl)methoxycarbonyl (CMOC) have been shown to light-activate in the visible region, and
by adding carboxylate substituents, these chromophores can be made more water
soluble,18 which makes them candidates for biological applications.19

5

Azobenzene is another popular choice as a photoactive moiety that has a different
light-activated mechanism than other caging groups. Azobenzene undergoes trans-cis
isomerization upon irradiation with UV light, resulting in a structural change instead of
photocleavage. Unlike the previously presented groups, nitrobenzyl and coumarin,
azobenzene has the ability to "photoswitch" and reverse back to trans, initiated either
thermally or upon irradiation with visible light. Many derivatives have been made to
adjust the wavelength, quantum yield, and to prevent the thermally activated
isomerization back to the trans configuration to have better control over the system with
light.20 Several examples in the literature have used azobenzene, from the reversible
photocontrol of oligonucleotide duplex formation,21-23 to the incorporation of azobenzene
derivatives in diblock copolymers for materials science applications.24-26 The reversible
isomerization of azobenzene is shown in Figure 1-3.

III. Light-activated oligonucleotides
Caging a wide variety of small and large biologically active molecules has been a
popular area of research and has had much success in recent years. Examples of caging
can be found for molecules including metal ions,27 peptides,28 oligonucleotides,29
proteins,30 and plasmids.31,32 This review will focus on literature pertaining to caging
short oligonucleotides that control gene expression, primarily antisense oligonucleotides.
Over the past two decades, several methods for controlling oligonucleotide
function with light have been developed.29 Caging oligonucleotides is challenging due to
6

their complexity and large size, and thus, many different methods have been explored.
Initial efforts towards light-activated oligonucleotides were made in 1995 by
Ordoukhanian et. al., with the design of photoresponsive DNA "building blocks" which
could be site-specifically incorporated into a short oligonucleotide synthesis, and
destabilize hybridization upon photolysis with 355 nm light.33 Another example of using
photoresponsive nucleobases to induce DNA strand breaks was presented in 2002 by
Dussy et. al.34 More commonly, strategies have been developed that involve the use of
caging groups on the nucleosides to disrupt Watson-Crick base pairing and destabilize
duplex formation until irradiation.35,36 This strategy has been used widely for a variety of
applications including siRNA,37-39 peptide nucleic acids,40,41 caged fluorescent
oligonucleotides,42

antisense

oligonucleotides,43-45

and

miRNA.43,46

A

cartoon

representation of these designs is represented in Figure 1-4 A-B.
Although caged nucleobases have proven effective towards light-activating
hybridization based functions of oligonucleotides, drawbacks of this approach include the
need for unique nucleobase monomers, which makes it difficult to design a generalizable
method for caging. Another drawback to this method is that typically multiple caging
groups are necessary to effectively disrupt hybridization which increases the light dose
necessary for uncaging. This can be especially problematic since many of these designs
use UV-active moieties, and high doses of UV irradiation can be damaging in biological
systems. For these reasons, our lab and others have moved towards caged hairpin and
circular caged designs.
7

A. Caged hairpin oligonucleotides
Caged hairpins consist of a biologically active strand and a shorter
complementary strand, covalently attached with one or more photocleavable linkers.
Through hybridization of a shorter blocking strand, the biologically active strand is
rendered inactive. Covalent attachment of the two complementary sequences achieves a
higher effective concentration, resulting in a higher thermal stability for the duplex.
While covalently held in the hairpin structure, the biologically active strand is unable to
bind to its target. Upon irradiation with UV light, the photolinker is cleaved which
destabilizes the duplex. This results in duplex dissociation, and more favorable
hybridization to the full length target. A schematic representation of a caged hairpin is
shown in Figure 1-6A.
Our lab has designed and synthesized various caged hairpins, for RNase Hmediated mRNA digestion, antisense oligonucleotides, and most recently, for harvesting
mRNA from single cells.47 Additional examples for caged hairpins have been presented
by the Chen lab.48-50 One of the first examples published by Tang and Dmochowski
reported a caged antisense DNA hairpin.51 This hairpin blocked function of a 20-mer
DNA when covalently attached to a blocking strand via a nitrobenzyl-based
heterobifunctional photocleavable linker. Upon photocleavage with 365 nm light,
antisense DNA was revealed to bind to target mRNA and recruit RNase H for mRNA
degradation. This design was applied to target c-myb, a hematopoietic transcription factor
in human K562 (leukemia) cells.52 A similar design was applied to caging an 18-mer
8

antisense negatively charged peptide nucleic acid.53 This caged antisense hairpin was
used to photomodulate gene expression in zebrafish embryos for two early developmental
genes, chordin and bozozok.
Additional efforts have been made towards caging antisense morpholinos, which
are currently the gold standard in achieving gene knockdown in many model
developmental organisms, including sea urchin, ascidian, zebrafish, frog, chick, and
mouse.54 Morpholinos (Figure 1-5) have been demonstrated to have high nuclease
resistance due to their highly modified backbone. Initial reports of caging morpholinos by
Shestopalov et al. involved a hairpin structure, where the morpholino, inhibitor sequence
and dimethoxynitrobenzyl moiety were linked through a Cu(I)-catalyzed Huisgen 1,3dipolar cycloaddition.48 Additional features of this design included 3′ fluorescein for
construct visualization in vivo. Successful photomodulation of zebrafish notail was
achieved with this design. Following up on this design, Shestopalov et al. reported an
additional caged morpholino with a simplified synthesis.49,50 A DMNB-based
bifunctional linker was used to conjugate the antisense morpholino and its
complementary inhibitor strand in three steps, starting with commercially available
morpholinos. Generalizable methods pertaining to inhibitor placement and length
optimization were also explored. Additionally, a bromohydroxyquinoline (BHQ)-based
linker for two-photon uncaging was presented.
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B. Circular caged oligonucleotides
More recently, caging of short oligonucleotides has been achieved through
circularization.55-59 By covalently attaching the 5′ and 3′ ends of the oligonucleotide with
a photocleavable linker so that it forms a circular structure, the oligonucleotide is
structurally restricted from hybridizing to a complementary target. A cartoon
representation of this design is shown in Figure 1-6. This design has many benefits that
arise from the lack of a blocking sequence. Primarily, the circularization scheme is
sequence independent. Additionally, there is no risk of the blocking strand having
biological activity and off-target effects after photolysis and dissociation. As there is only
one photocleavable linker in most circular designs, this significantly lowers the light dose
necessary for uncaging.
Initial reports of circular oligonucleotides were by Richards et al. where a
photolabile circular DNAzyme was enzymatically synthesized using T4 ligase and
photomodulation of RNA digestion was achieved.58 Tang et al. presented the first
example of photomodulating RNA digestion by RNase H through the synthesis of lightactivated circular DNA antisense oligonucleotides.57 The first example of a caged circular
morpholino was reported by Yamazoe et al.,55 shortly followed by Wang et al. who also
caged a 25-mer morpholino by linking the two ends in a circular structure with a
nitrobenzyl photocleavable moiety.56 These caged cMOs were successfully used to
photomodulate early developmental genes in zebrafish embryos with 365 nm light.
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Yamazoe et al. compared background activity between circular and hairpin structures
and found significantly less background activity in vivo with circular constructs.

C. Other designs of caged oligonucleotides
Another method for caging oligonucletides reported by the Dmochowski lab is an
"RNA bandage" design that provides a method of blocking mRNA translation and
restoring it upon irradiation with UV light.60 These constructs perform opposite of the
previously described caged hairpins and circular caged oligonucleotides, as they can
regulate gene expression from "off to on" as opposed to "on to off". A schematic
representation is shown in Figure 1-7A. Bandages were designed and synthesized using
2′-OMe RNA antisense oligonucleotides and linked by a nitrobenzyl-based
photocleavable moiety that activates with 365 nm irradiation. These RNA bandages were
demonstrated to be successful at photomodulating in vitro translation.
A similar design strategy was implemented by Tallafuss et al. to cage an antisense
morpholino.61 In this design, two shorter blocking sequences were linked with a
nitrobenzyl photocleavable moiety and hybridized to a 25-mer target morpholino for
turning genes from "off to on" with light (Figure 1-7A). Additionally, this design can be
used for "on to off" gene photomodulation by linking two shorter MO sequences together
with a nitrobenzyl moiety to form a full length active morpholino that is able to bind to
an mRNA target (Figure 1-7B). Upon UV light exposure, the two shorter MO sequences
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are liberated, resulting in dissociation from the mRNA. This technology is commercially
available through Gene Tools (Philomath, Oregon).
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Figure 1-1. Structure of o-nitrobenzyl and derivatives

13

Figure 1-2. Structure of MCM ester (coumarin) and derivative, brominated 7hydroxycoumarin-4-ylmethyl ester (Bhc).
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Figure 1-3. Azobenzene structure
Azobenzene changes from trans-cis configuration upon UV irradiation and cis-trans thermally, or
upon visible irradiation.
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Figure 1-4. Cartoon representation of A) caged backbone, or photocleavable bases and B)
caged nucleobases.
A) The oligonucleotide hybridizes to the target (depicted as mRNA) until irradiated with UV
light. B) Caging groups on bases disrupt Watson-Crick base pairing until irradiation with UV
light. Caging groups are shown in red, antisense oligonucleotide sequence is shown in green, and
target (mRNA) is shown in gray.
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Figure 1-5. Structure of antisense morpholino
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Figure 1-6. Cartoon representation of A) caged antisense hairpin and B) circular antisense
oligonucleotide.
A) An antisense sequence is covalently attached to a blocking sequence by a photocleavable
linker. This blocking sequence can vary in length and placement. B) An antisense sequence is
covalently held in a circular structure to prevent target binding. Upon UV irradiation, the
antisense oligonucleotide is liberated and able to hybridize to a complementary target. Caging
groups are shown in red, antisense oligonucleotide sequence is shown in green, blocking
sequence is shown in blue, and target (mRNA) is shown in gray.
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Figure 1-7. Cartoon representation of A) RNA bandage or Photomorph and B) Photomorph
"off to on" antisense oligonucleotide.
A) Two shorter antisense sequences are joined by a photocleavable group to form a full length
sequence that can hybridize to target mRNA. Upon irradiation, shorter sequences dissociate and
liberate mRNA. B) Two shorter blocking sequences are joined by a photocleavable group to form
a full length sequence that can hybridize block morpholino function. Upon irradiation, shorter
sequences dissociate and activate the morpholino. Caging groups are shown in red, antisense
oligonucleotide sequence is shown in green, blocking sequence is shown in blue, and target
(mRNA) is shown in gray.
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III. Moving away from ultraviolet light activation

A. One-photon vs. two-photon activation
The primary goal of caged compounds is the ability to control biological
processes with light with high spatiotemporal resolution. Although much progress has
been made towards this goal through the use of 1-photon active moieties such as the UV
active o-nitrobenzyl group and derivatives, significant improvements can be achieved
with the implementation of two-photon photolinkers. The use of 2-photon activation in
caged compounds can provide even greater spatial resolution in three dimensions through
the addition of depth control.62
Two-photon photolysis replaces the absorption of one photon with two longerwavelength, lower-energy photons, typically in the NIR region, of equivalent total
energy. The simultaneous absorption of these photons is governed by the light intensity
and the two-photon absorption cross section, measured in GM (Göppert-Mayer). A GM is
equal to 10-50cm4 s photon-1, therefore, confining the uncaging event to a very small
region of focus with negligible out of focus irradiation.63 This allows for uncaging in
very small regions of interest and volumes as small as 1 femtoliter.4 Additional benefits
of NIR light used for two-photon uncaging is significantly less scattering than shorter
wavelength light, and less damage to biological systems compared to UV light.64
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B. Two-photon photolinkers
Nitrobenzyl and coumarin derivatives have been shown to be two-photon active,
however their two-photon absorption cross sections are very low, in the 0.01 - 0.1 GM
range.65 Although NIR light is significantly less damaging than UV light, high laser
powers required to activate compounds with such low two-photon cross sections result in
heating and toxicity due to water strongly absorbing 700-900 nm light.66 For this reason,
it is necessary to develop two-photon caging groups with significantly higher crosssections (3-30 GM).63
There are few applications that have been demonstrated for two-photon caged
biomolecules, likely due to the limited availability of two-photon caging groups. Some
examples of two-photon caged compounds using coumarin derivatives are caged calcium,
azid-1,67 and caged glutamate.68 Although successful two-photon uncaging has been
achieved with these caged compounds,69,70 cross-sections were measured to be below the
3 - 30 GM target level, therefore requiring high levels of laser power.4

C. [Ru(bpy)2XY]n+ ligand dissociation with visible and two-photon light
Octahedral Ru(II) polypyridyl complexes have been shown to be a promising
method of caging molecules for release with visible and two-photon excitation.
Specifically, complexes of the type [Ru(bpy)2XY]n+, a Ru(II) center with two bipyridines
and two monodentate ligands (Figure 1-8), undergo photochemistry resulting in the
photodissociation of one or both monodentate ligands.71 Initial reports of these complexes
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were published by Dwyer et al.,72 with in-depth photochemical studies followed two
decades later.73 Photochemical reactions typically follow equation (1) and sometimes also
equation (2), where X and Y are monodentate ligands, and S is solvent.
h
h

A general mechanism of photorelease is demonstrated through the Jablonski
diagram in Figure 1-9. Upon irradiation, absorption into the MLCT (typically 400-500
nm) populates the single 1MLCT band. Intersystem crossing (ISC) occurs, populating the
triplet 3MLCT state. This process occurs very rapidly, on the order of 40 fs measured for
Ru(bpy)32+.74 Decay can occur through multiple pathways, non-radiative (nr), radiative
(rad), and in the case of [Ru(bpy)2XY]n+, cross-over to the ligand field (3LF) state where
ligand dissociation occurs.75 Population of the ligand field state is thermally activated,
and directly correlates with the energy gap between 3MLCT and 3LF. At a given
temperature, a higher energy 1MLCT results in a higher energy 3MLCT band and thus, a
smaller gap between 3MLCT and 3LF. This results in a blue-shifted MLCT ground-state
absorption band and therefore, a higher yield of photosubstitution (i.e., a higher quantum
yield). In contrast, a larger gap between the 3MLCT and 3LF will result in lower quantum
yields of photosubstitution.75
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D. [Ru(bpy)2(X)2]2+ as a photolinker
The tunable photophysical properties of [Ru(bpy)2XY]n+ make these complexes
very attractive for caging applications. The MLCT in the visible region is beneficial for
use in biological systems, as visible light is far less damaging to cells, and also penetrates
tissue samples deeper due to the longer wavelength.71 Additionally, as shown in Scheme
1-1, the mechanism of uncaging is through a ligand-exchange process instead of a photocleavage process which allows for very clean and efficient whole-molecule uncaging.
Many examples of whole-molecule caging with these ruthenium complexes have been
presented in the literature.
The first example of ruthenium caging of a biologically relevant molecule was
presented by Zayat et. al. in 2003 with the caging of 4-aminopyridine.76 In this example,
4-aminopyridine (4-AP), a neurocompound that blocks K+ channels,77 was cooordinated
directly to Ru(bpy)2Cl2 through the amine. The resulting water-soluble compound,
[Ru(bpy)2(4-AP)2]Cl2 had a MLCT centered at 489 nm and underwent successful
uncaging, as confirmed by a free 4-AP ligand seen by 1H NMR spectroscopy.
Experiments using [Ru(bpy)2(4-AP)2]Cl2 showed successful uncaging and neuronal
stimulation in a leech ganglion, with no toxicity observed. Additional compounds were
designed by the Etchenique lab using similar strategies, including a cholinergic agonist
nicotine, [Ru(bpy)2(Nic)2]2+,78 and a caged γ-aminobutyric acid (GABA).79 These caged
compounds all coordinated to the ruthenium through an amine.
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The octahedral ruthenium center on [Ru(bpy)2XY]n+ provides flexibility in
coordination chemistry. The choice of ligand depends primarily on the desired
photophysical characteristics, such as wavelength and quantum yield, providing excellent
potential for designing photolinkers. Selecting ligands that are much weaker σ-donors
will result in an electronically depleted Ru(II) center, thus, shifting the activation to
higher energy (shorter wavelengths). This blue-shifting results in a significantly higher
quantum yield.80 Another consideration is whether or not one or both monodentate
ligands will dissociate. This also depends on the electronics of the ligands. For example,
if X and Y are different ligands, substitution will occur at the ligand that is a weaker σdonor. In cases where the monodentate ligands are identical, the substitution will proceed
on one ligand to form the mono-aquo product, unless the ligand is a weaker σ-donor than
the solvent, in which case both ligands will be exchanged.71
Another benefit of using [Ru(bpy)2XY]n+ compounds as photolinkers is their
demonstrated two-photon activation. Salierno et al. presented a caged glutamate,
Ru(bpy)2(PMe3)(Glu), which could be efficiently uncaged with one-photon (450 nm) or
two-photon (800 nm) light.81 The two-photon cross section for this caged glutamate was
determined to be 0.14 GM. Additional examples of two-photon activation of
[Ru(bpy)2XY]n+ compounds include the two-photon uncaging of a caged dopamine,

[Ru(bpy)2(PMe3)(Dopa)](PF6)2 which has an even higher two-photon cross-section of
0.24 GM.82 These two-photon cross sections are significantly higher than what has been
reported for two-photon activation of nitrobenzyl or coumarin derivatives, and there.is
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potential for tuning the Ru ligands to achieve the desired 3-30 GM target. Compounds of
the type [Ru(bpy)2XY]n+ are promising for developing a library of photoactive moieties,
as they are widely tunable depending on the coordinated ligands.
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Figure 1-8. General structure of [Ru(bpy)2XY]n+ complexes
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Figure 1-9. Jablonski diagram showing mechanism of photo-triggered ligand dissociation
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Scheme 1-1. General scheme for single ligand exchange of [Ru(bpy)2XY]n+ in H2O
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IV. Light-activated polymersomes

A. Introduction to polymersomes
Polymersomes are a class of synthetic vesicles that self-assemble from
amphiphilic diblock copolymers.83 Polymersomes have attracted much attention since
their initial discovery by Hammer, Discher, and Eisenberg a little over a decade ago84,85
due to their robustness, tunability, ability to mimic biological membranes and the ability
to encapsulate a broad variety of molecules. Polymersomes are composed of two
components, a large hollow aqueous core, and a thick hydrophobic membrane which
separates the aqueous core from the outer medium. These two structural components
provide versatility in encapsulation possibilities, from hydrophobic drugs (ie, paclitaxel,
doxorubicin, quantum dots) encapsulated in the membrane, to small molecules and large
biomolecules (i.e., siRNA, DNA, plasmids, proteins, enzymes) encapsulated in the
aqueous core.
Polymersomes have many benefits over liposomes as carrier systems, namely,
they are fully synthetic which provides the possibility to tune many characteristics such
as membrane thickness, vesicle size, and vesicle composition. Since polymersomes are
comprised of high molecular weight polymers as opposed to small phospholipids like
liposomes, membrane thickness typically spans from 3-30 nm in comparison to 3-5 nm.83
These high molecular weights also offer benefits such as decreased membrane
permeability and enhanced mechanical strength. Additionally, polymersomes have been
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shown to have significantly longer circulation times in vivo than unmodified liposomes.86
Circulation time of liposomes is typically on the order of hours,87 but can be increased by
functionalizing the outer surface with poly(ethylene glycol) (PEG), known as "stealth
liposomes".88 In contrast, polymersomes have intrinsically long circulation times due to
their composition.
Polymersomes can generally be prepared by two different methods, phaseinversion, and polymer rehydration. The phase-inversion technique involves dissolving
the diblock copolymer in an organic solvent, followed by hydration with aqueous solvent.
Typically, this process yields fairly uniform nanovesicles that can be tuned through
polymer concentration and organic-to-water ratio.83 This process results in self-assembly
by increasing the interfacial tension between the hydrophobic polymer blocks and the
hydration solution. The polymer rehydration method involves dissolving the diblock
copolymer in organic solvent and forming a thin film by evaporation of the organic
solvent. Self-assembly is promoted by hydration with water. With the polymer
rehydration technique, vesicles are formed as the water permeates the polymer film
through defects, causing the polymer to lift from the surface. Polymer rehydration
typically yields larger vesicles that can be made smaller and more uniform through
extrusion.89
B. Light-activated polymersomes
Much attention has been dedicated to designing "smart" polymersomes, or
polymersomes that respond to a stimulus to release cargo. This stimulus can be an
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internal or external trigger such as degradation by hydrolysis, temperature, pH, magnetic
fields, or light.90 This review will focus on examples of polymersomes that undergo
membrane disruptions in response to light. Light-responsive polymersomes are an
attractive method of controlled release because light can be easily externally manipulated
for release of cargo with high spatial and temporal resolution.
One such system by Mabrouk et al. used an azobenzene group incorporated
within the diblock copolymer to promote rapid membrane disruptions in response to UV
light.91 Asymmetric micron-sized polymersomes were assembled through two block
copolymers, an inert copolymer, polyethyleneglycol-polybutadiene (PEG-b-PBD), and a
liquid crystal based copolymer, PEG-b-PMAazo444 (PAzo). The liquid crystal block
contained an azobenzene group which underwent a trans-to-cis configurational transition
in response to UV light. The isomerization caused a conformational change in the block
from a rod to a coil, which induced an area difference between the two polymer
monolayers sufficient to trigger membrane rupture.
Another example of a light-responsive micron-sized polymersome system was
presented by Robbins et al.92 This system was the first example of a photoactive
polymersome formed by incorporating a protein in the aqueous interior and a meso-tomeso ethyne-bridged bis[(porphinato)zinc] (PZn2) chromophore in the membrane.
Micron-size vesicles were self-assembled using a polyethylene oxide-polybutadiene
(PEO30-PBD46, denoted OB29) diblock copolymer. Two different proteins, horse spleen
ferritin (HSF) or iron-free apoferritin (HSAF), were encapsulated within the aqueous
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core. Incorporation of the PZn2 chromophore into the vesicle's hydrophobic membrane
allowed for light absorption of near-UV to near-IR wavelengths. Irradiation with 488,
543, and 633 nm induced irreversible membrane deformities ranging from "budding" to
complete rupture. It was hypothesized that the protein associated with the inner
membrane, causing asymmetrical membrane deformation upon PZn2 energy dissipation
as heat, which ultimately resulted in membrane rupture. A small molecule, biocytin, was
encapsulated within the core and 25-50% release was demonstrated upon light exposure.
The work by Robbins et al.92 was further explored by Kamat et al.93 and
subsequently resulted in a general method for producing photoresponsive micron-sized
vesicles with chromophore PZn2 in the hydrophobic membrane. Following up on the
work by Robbins et al., it was hypothesized that any luminal solute that associates with
the inner leaflet of the membrane can induce polymersome rupture when combined with
PZn2 in the membrane. Dextran was investigated as a luminal encapsulant due to its
biocompatibility and aqueous solubility. It was shown that inclusion of dextran could
induce membrane instability upon irradiation. Studies were performed varying the size of
the dextran and molecular weight of the polymer, and it was shown that
photoresponsiveness increased with molecular weight and dextran concentration.
Additional work by Kamat et al. explored this system for use as a membrane stress
sensor.94 cIt was demonstrated that PZnn fluorophores underwent significant red emission
shifts as a response to environmental crowding within a polymersome membrane.
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To date, only one example exists of a photoresponsive nanoscale polymersome. It
is important to develop light-responsive vesicles on the nano-scale for biological
applications, as micron vesicles are not sized appropriately for in vivo experiments.
Mammalian cells, such as HeLa cells, are typically 10-20 µM in diameter, therefore it is
necessary to develop much smaller carrier systems for these applications. Additionally,
passive uptake of polymer-based nanoparticles by red blood cells has been shown to
occur for particles less than 200 nm.95
Cabane et al. presented a photocleavable amphiphilic diblock copolymer,
poly(methyl caprolactone)-ONB-poly(acrylic acid) (PMCL-ONB-PAA) that selfassembled into micelles and 150 nm polymersomes.96 qcThis block copolymer contained
an o-nitrobenzyl moiety as a photocleavable linker between the hydrophilic and
hydrophobic polymer chains. UV-irradiation induced a successful cleavage of the diblock
copolymer chains, both in THF and aqueous solution, as well as in self-assembled
vesicles. This work was further extended to probe the ability of this system to encapsulate
and release two small molecules, as well as a large biomolecule, green fluorescent
protein.97 Irradiation with 365 nm light induced polymersome disintegration within
minutes. Upon irradiation, cargo was released and polymersome morphology was shown
by cryo-TEM to transition from vesicles to micelles. This nanoscale system provides a
promising route to deliver cargo in vivo with UV light, and can be tuned for delivery
needs by altering the number of photocleavable moieties in the polymer.
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Figure 1-11. General schematic of a polymersome.
The hydrophobic membrane, shown in gray, is composed of a hydrophobic polymer (black) and
hydrophilic polymer (green). A common diblock copolymer used for polymer self assembly is
PBDx-PEOy. The hydrophilic lumen for encapsulating cargo is shown in blue.
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Figure 1-12. Cartoon of a PEG-b-PBD/PEG-b-PMAzo444 polymersome and response to UV
light.
Under UV illumination, isomerization of the azobenzene induces a conformational change of
the diblock copolymer, resulting in vesicle rupture.
Figure adapted from E. Mabrouk. et. al. P.N.A.S. 2009, 106, 7294-7298
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Figure 1-13. Nitrobenzyl-linked light-responsive polymersome.
Chemical structure of the poly(methyl caprolactone)-ONB-poly(acrylic acid) diblock copolymer
and degradation products upon UV irradiation are shown.
Figure adapted from E. Cabane et. el. Soft Matter, 2011, 7, 9167–9176
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V. Research Aims
Work presented in this thesis demonstrates three unique designs for biomolecular
caging, all responsive to different wavelengths of light. The first two designs involve the
site-specific incorporation of a caging moiety, and the third design involves encapsulation
within a light-activated polymersome nanocarrier. Specifically, Chapter 2 presents a
caged antagomir for the regulation of let-7 miRNA, in zebrafish embryos. This caged
antagomir provides the ability to block the activity of a miRNA in vivo upon
photoactivation with 365 nm light. Additionally, Chapter 2 presents a caged miRNA,
providing a method of introducing an exogenous miRNA into zebrafish embryos and
activating it upon irradiation. Used together, these two constructs provide the ability for
bidirectional control of a miRNA. Chapter 3 focuses on the design, synthesis, and
application of a ruthenium-based visible-light photolinker, RuBEP. Two antisense
morpholinos were circularized with RuBEP through click-chemistry, and activated in
zebrafish embryos with 450-nm light. Chapter 3 demonstrates an encapsulation-based
approach for caging through the use of photo-responsive nano-polymersomes. These
nano-polymersomes were used to encapsulate oligonucleotides, small molecules (FITC),
and metal ions (Zn2+ and Ca2+) and cargo was released with 488 nm light.
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Caged oligonucleotides for bidirectional photomodulation of let-7 in
zebrafish embryos

This chapter was adapted from J.C. Griepenburg et. al. Bioorg. Med. Chem. 2013, 21, 6198-6204.
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I. Introduction
MicroRNA (miRNA) is a large class of non-coding RNA that interferes with posttranscriptional gene expression through binding to the 3′ UTR of mRNA. Since the
discovery of the first miRNA in 1993, lin-4, it has been found that miRNAs are abundant
short RNAs that have important roles in normal developmental and cellular processes, as
well as in human disease.1,2
Unlike short interfering RNA (siRNA), a single miRNA can interfere with
multiple gene targets, as binding does not require perfect complementarity except in the
5′ seed region.3,4 This makes elucidation of miRNA function particularly challenging as a
single miRNA can have multiple roles that vary with cellular location and timing. 5 Lossof-function miRNA studies are useful in determining miRNA pathways,6 but fall short in
identifying multiple miRNA functions with spatial and temporal resolution.
Loss-of-function studies of miRNA are most commonly performed using antimiRNA oligonucleotides, also known as antagomirs.7 These oligonucleotides are
perfectly complementary to the biologically active sequence of the miRNA and sterically
block function by outcompeting the target mRNA. Various oligonucleotide backbone and
ribose modifications have been previously studied to improve the efficacy of antagomirs,
such as phosphorothioation, 2′-F RNA, 2′-OMe RNA, locked nucleic acid (LNA), as well
as morpholinos which are commonly used in antisense applications.4 Reverse
complementary 2′-OMe RNA can block miRNA function in C. elegans, based on
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nuclease resistance and increased binding affinity as shown by melting temperature (Tm)
studies.6,8
The complexity of gene expression patterns established in metazoan early
development has motivated the creation of biochemical tools for controlling genes with
higher spatial and temporal resolution.9-12 Light-activated approaches show considerable
promise as near-UV/Vis/near-IR light of desired wavelength can be applied dosedependently and in a spatially and temporally controlled manner. In recent years, there
have been advances in caging siRNA, allowing for spatial and temporal control of the
RNA interference (RNAi) pathway. In 2005 the Friedman lab first reported caged siRNA
by labeling the phosphate backbone of a siRNA duplex with 1-(4,5-dimethoxy-2nitrophenyl)ethyl moieties, which blocked the siRNA-RISC interaction before
photolysis.13 Additional work by the Friedman lab blocked siRNA activity with a larger
photocleavable cyclo-dodecyl (dimethoxy-2-nitrophenyl)ethyl moiety.14 The addition of
steric bulk to the terminal phosphates prevents Dicer and nucleases that could remove the
caging group, from interacting with the siRNA. Most recently, Kala et. al. presented a
method of photoregulating siRNA with a tetra-DMNPE–modified duplex RNA, where
the terminal phosphates are caged with regiospecific DMNPE.15 The terminal DMNPE
groups effectively cage native siRNA until irradiated with 365 nm light.
While these and other16,17 advances have been made towards spatiotemporal
control of the RNAi pathway, there has been much less reported for the biochemical
modulation of miRNA. Recently, Zheng et al. reported a novel photoactivatable
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antagomir for controlling miRNA in C. elegans.18 In this work, a caged hairpin-like
structure was created by attaching a complementary blocking strand to the antagomir via
a coumarin moiety. After irradiation, dissociation of the antagomir became more
favorable, allowing binding to a miRNA target.18 Additionally, Connelly et al. reported a
method of photomodulating miRNA in cells by attaching caging groups on specific bases
of the miR-122 and miR-21 antagomirs.19 Here, we expand upon the caged hairpin
antagomir. Moreover, we provide the first example of a caged miRNA, which makes it
possible to “turn on” exogenously supplied miRNA via photoactivation.
Let-7, the miRNA of interest in this study, was discovered in 2000 in C. elegans
by Reinhart et al. and was shown to play an important role in developmental timing.20
Interestingly, this particular miRNA is evolutionarily conserved across humans, flies,
mice, and zebrafish.21 Let-7 miRNA was chosen for the current investigation due to the
developmental arrest caused by overexpression in Danio rerio (zebrafish) embryos,
resulting in a readily observable phenotype.5 This phenotype is characterized by reduced
head and eye formation, shortened tail, and limited yolk sack extension.5 Let-7 miRNA is
not endogenously expressed in zebrafish embryos until 48 hours post fertilization (hpf),
but an early let-7 expression phenotype can be induced by injecting the let-7 miRNA at
the one-cell stage. This phenotype is clearly visible at 24 hpf.5 Representative examples
of zebrafish embryos showing the let-7 early induction phenotype are shown in Figure 21. This provides a miRNA-vertebrate model system to photoregulate miRNA in both
directions--from "off to on" and "on to off".
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Novel oligonucleotide constructs were developed for regulating miRNA in
zebrafish embryos: two caged hairpin antagomirs (CHANT1, CHANT2) for blocking
miRNA function with 365 nm light, as well as a caged circular miRNA (CIRClet7) for
introducing exogenous miRNA into a system with 365 nm light. The design of CHANT1
was guided by our lab’s experience in developing caged hairpins with a single
photocleavable linker for photoactivating antisense oligonucleotides in zebrafish
embryos.22 This is similar to the caged hairpin antagomir recently published by Zheng et
al.18 In CHANT2, we expand upon this design by incorporating a longer blocking sense
strand and second photocleavable linker. Finally, the circular miRNA expands on our
previous circular design involving the 10-23 DNAzyme,23 and also draws inspiration
from several notable circular caged oligonucleotide constructs that have recently been
published.24-26

II. Experimental procedures

A. Synthesis, purification, and characterization of light-activated miRNA
antagomirs: CHANT1 and CHANT2
CHANT1 and CHANT2 were synthesized on a 1 µmol scale using published
methods for oligonucleotide synthesis on solid support using an ABI 394 DNA
synthesizer.27,28 CHANT1 and CHANT2 were cleaved from solid support using
concentrated ammonium hydroxide for 16 h, and HPLC purified (Figure 2-2). A reverse49

phase C18 semi-preparatory column was used on an Agilent 1100 HPLC system. A
gradient of 10% - 80% acetonitrile in 0.05 M triethylammonium acetate (TEAA) was
used for purification of all oligonucleotides containing a dimethoxytrityl (DMT)
protecting group (Table 2-1). The DMT protecting group was removed using 80% glacial
acetic acid for 20 min at rt. A NAP-5 column was used for buffer exchange after
purification and deprotection. After HPLC purification, approximately 100 nmol of pure
material was isolated.

Table 2-1. Gradient for HPLC purification of CHANT1 or CHANT2 after cleavage from
solid support.
A gradient of 0.05 M triethylammonium acetate in H2O was used with a Zorbax reverse-phase
C18 column. The column was heated to 40 °C during purification.

Time (min)

% Acetonitrile

% 0.05 M TEAA

0.0

90

10

40.0

40

60

50.0

20

80

B. Synthesis and purification of CIRClet7
CIRClet7 was synthesized on a 1 µmol scale using published methods for
oligonucleotide synthesis on solid support using an ABI 394 DNA synthesizer.29 A
FMOC-protected amino solid support was used on the 3′ end and a disulfide
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phosphoramidite was incorporated at the 5′ end. The construct was cleaved from solid
support using concentrated ammonium hydroxide for 16 h, and HPLC purified (Figure 22A). A reverse-phase C18 column was used on an Agilent 1100 HPLC system. A
gradient of 10% - 80% acetonitrile in 0.05 M triethylammonium acetate (TEAA) was
used for purification of all oligonucleotides containing a dimethoxytrityl (DMT)
protecting group (Table 2-2B). The DMT protecting group was removed using 80%
glacial acetic acid for 20 min at rt. A NAP-5 column was used for buffer exchange and
desalting after purification and deprotection. After HPLC purification, approximately 30
nmol of pure material was attained.
The 3′ amine was reacted with an excess of sulfo-EMCS linker. A 0.4 mg/mL
linker solution was prepared in 0.1 M PBS buffer, pH 7.2. The reaction was allowed to
proceed for 30 min at 37 °C and quenched by removing excess sulfo-EMCS with a NAP5 column. The 5′ disulfide was then reduced with TCEP at 37 °C, and the circularization
reaction with 5′ thiol was allowed to proceed for 24 h. Circularization was confirmed by
visualizing bands by gel electrophoresis. Circularization yield was determined by band
quantification using ImageQuant TL 7.0 Image Analysis Software with the rubber band
background subtraction method. Circular product was purified from linear starting
material using anion exchange HPLC (Figure 2-3B). A Dionex DNAPac PA100 anion
exchange column was used with a gradient of NaClO4 in the presence of Tris-Cl pH 8.0
to separate linear starting material from circularized product (Table 2-2B).
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Table 2-2. Gradients for HPLC purification of CIRClet7 A) after solid-phase synthesis and
B) after circularization.
A) Zorbax C18 column heated to 40 °C during purification B) DNAPac PA100 column heated
to 60 °C during purification.

A)
Time (min)
0.0
40.0
50.0

% Acetonitrile
90
40
20

Time (min)
0.0
0.1
26.1
26.5
34.5
35.0
50.0

% H 2O
88
58
32
0
0
88
88

% 0.05 M TEAA
10
60
80

B)
% 0.25 M Tris-Cl pH 8
10
10
10
0
0
10
10

% 0.375 M NaClO4
2
32
58
100
100
2
2

C. Characterization
Melting temperature analysis was performed on a Beckman Coulter DU800
spectrophotometer with a Peltier temperature controller and Tm analysis software. A
solution of 1 µM oligonucleotide in 50 mM NaCl in deionized H2O was used for all
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melting temperature experiments. Samples were irradiated using a Spectroline TR-365R
transilluminator delivering 9 mW/cm2 centered at 365 nm for 10 min. Melting
temperatures were analyzed by varying the temperature between 15 °C and 90 °C at a
rate of 1 °C per min, in both forward and reverse directions.
Gel electrophoresis was performed using a 20% polyacrylamide gel containing 7
M urea. Gels were run at 300 V for 45 min and stained with ethidium bromide. Gels were
imaged with a GE Typhoon FLA 7000 imager. Masses were confirmed by the Wistar
Proteomics Facility using an Applied Biosystems Voyager 6030 with 3-hydroxypicolinic
acid (3-HPA) as matrix (Table 2-3, Figure 2-4).

Table 2-3. Masses determined for CHANT1 and CHANT2 by MALDI-TOF MS.

CHANT1

Expected Mass
(m/z)
11,683

MALDI Mass
(m/z)
11,466

CHANT2

14,336

14,498

D. In vivo studies
Zebrafish embryos were obtained from CDB Zebrafish Core Facility at the
University of Pennsylvania. Both Tu and TLF wildtype embryos were used for these
studies. Zebrafish embryo injection solutions were prepared to contain a final
concentration of 0.1 M KCl and 0.25% phenol red dye. All injections were performed at
the one-cell stage and injected into the cell compartment only. A Harvard Apparatus PLI53

100 pico-injector was used to inject controlled volumes. Injection volume was calibrated
to dispense 8 - 10 nL per embryo. Zebrafish embryos were incubated at 28 °C in E3
zebrafish medium.30 All embryos were incubated in the dark, except for irradiated
samples which were exposed to near-UV light for the stated time and returned to the dark
incubator. Embryo micrographs were collected at 24 hpf with an Olympus FV1000 laser
scanning confocal microscope using transmitted light imaging. A 10x air objective was
used for single embryo imaging.

E. Materials
2′-OMe RNA phosphoramidites for solid-phase oligonucleotide synthesis and all
modified phosphoramidites, including CPG solid supports, were purchased from Glen
Research (Sterling, VA). Product numbers for photocleavable spacer phosphoramidite,
amino modifier CPG, and thiol modifier phosphoramidite are 10-4913-90, 20-2957-01,
10-1926-90, respectively. N-Ɛ-Maleimidocaproyl-oxysulfosuccinimide ester (SulfoEMCS) linker was purchased from Thermo Scientific (Pierce Protein Biology Products).
NAP-5/10 desalting columns were purchased from GE Healthcare. Let-7 miRNA (5′UGAGGUAGUAGGUUGUAUAGUU-3′)

was

Technologies (IDT).

54

ordered

from

Integrated

DNA

Figure 2-1. let-7 early induction phenotype.
Zebrafish embryos injected at the 1-cell stage with 10 M let-7 miRNA show the let-7 early
induction phenotype when imaged at 24 and 50 hpf (right images), compared to un-injected
wildtype (Tu x Tu) embryos (left images). The early induction let-7 miRNA phenotype is
characterized by decreased head formation, shortened tail, and yolk that fails to extend along the
tail.
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Figure 2-2. HPLC trace for CHANT1.
Purification of CHANT1 after cleavage from solid support was performed using a Zorbax C18
column with a gradient of 0.05 M triethylammonium acetate in H2O. Column was heated to 40 °C
during purification. Product eluted at 30 - 31 min with gradient in Table 2-1.
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A

B

Figure 2-3. HPLC traces for purification of CIRClet7.
A) Purification of linear oligonucleotide after cleavage from solid support was performed using a
Zorbax C18 column with a gradient of 0.05 M triethylammonium acetate in H 2O. Column was
heated to 40 °C during purification. Retention time of product was 46 min. B) Purification of
circular product after circularization procedure using a DNAPac PA100 column with a gradient
of 0.25 M Tris-Cl pH 8 and 0.375 M NaClO4 in H2O (adapted from manufacturer protocol).
Column was heated to 60 °C during purification. Retention time of CIRClet7 was 34 min.
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Figure 2-4. Masses determined for A) CHANT1 and B) CHANT2 by MALDI-TOF MS.
MALDI-MS was performed by the Wistar Proteomics Facility at the University of Pennsylvania.
All masses were attained in linear negative mode, using 3-hydroxypicolinic acid (3-HPA) matrix.
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III. Results and discussion

A. Photoactivatible miRNA antagomir: CHANT1
A caged hairpin antagomir (CHANT1) was designed and synthesized to “turn off”
let-7 miRNA with a low dose of 365 nm irradiation. This antagomir consisted of a 22mer oligonucleotide synthesized with all 2′-OMe RNA bases (Figure 2-5). The function
of this antagomir was inhibited by a shorter 12-mer 2′-OMe RNA blocking strand. The
antagomir and blocking strand were covalently attached by a nitrobenzyl photocleavable
linker, PL (shown in red). Prior to photolysis, PL stabilized the hairpin hybrid form,
thereby blocking the function of the antagomir. Upon near-UV irradiation, PL was
cleaved, resulting in a destabilized hybrid. The photoactivated 22-mer 2′-OMe RNA
antagomir can readily hybridize to the complementary miRNA and sterically block its
function.
In designing CHANT1, a balance was struck between antagomir blocking
efficiency and restoration of antagomir function post-irradiation. In principle, all
antagomir nucleotides can be sterically blocked with a 22-mer blocking sequence;
however, this would disfavor dissociation post-irradiation. For this particular construct, a
12-mer blocking strand was chosen to block the antagomir at the 5' seed region, as this 68 nucleotide sequence has been shown to be important in miRNA-mRNA target
recognition.31,32 Additionally, terminating the blocking sequence with a guanine or
cytosine base should result in a more stable hybrid due to the increase in hydrogen
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bonding. For this reason, the placement and length of the blocking strand for this
particular sequence was chosen to be a 12-mer as shown in Figure 2-5.
CHANT1 was synthesized by solid-phase synthesis, isolated by HPLC
purification (Figure 2-2, Table 2-1)), and confirmed by MALDI-TOF MS to have the
correct mass (Figure 2-4, Table 2-3). Melting temperature analysis has proved to be a
useful tool to determine nearly the optimal length of the blocking strand. Melting
temperature analysis showed a CHANT1 melting temperature of

85 °C, indicating

favorable duplex stability. The Tm dropped to 64 °C post-photolysis, decreasing the
melting temperature (∆Tm) by at least 21 °C (Figure 2-6). This ∆Tm indicates significant
photomodulation of duplex stability and is comparable to many caged hairpins
synthesized in our laboratory.33-35 However, the post-photolysis Tm of 64 °C suggests that
a significant amount of antagomir remains bound to the blocking strand (and therefore
inactive), even after uncaging.
To confirm the efficacy of the exogenous let-7 miRNA in vivo, a 10 µM solution
was injected into zebrafish embryos at the one-cell stage (n = 35). Injection resulted in
the let-7 miRNA early induction phenotype in 92% of embryos (Figure 2-1). In vivo
studies with CHANT1 were subsequently performed by co-injecting a 10 µM solution of
let-7 miRNA, together with varying concentrations (40 - 100 µM) of CHANT1 into
embryos at the one cell stage. CHANT1 at 50 µM exhibited high activity with minimal
toxicity. Thus, a 10 µM solution of let-7 miRNA and 50 µM CHANT1 was subsequently
injected into all zebrafish embryos at the one-cell stage. Half of the injected embryos
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were allowed to incubate at 28 °C in the dark, while the other half were irradiated at 1
hpf. A near-UV transilluminator was used to irradiate the embryos for 10 min in E3
zebrafish media. The embryos were incubated for 24 h at 28 °C, and then imaged to
determine phenotypic response. Of the embryos that were irradiated with 365 nm light (n
= 21), the majority (86%) developed normally, indicating that the caged antagomir was
photoactivated and able to block let-7 miRNA function (Figure 2-7). In the non-irradiated
embryo group (n = 15), the majority (80%) developed with the let-7 miRNA early
induction phenotype, as expected. However, a significant minority (20%) of the embryos
developed normally (Figure 2-10), indicating incomplete caging of CHANT1. Although
this caged hairpin exhibited a very high Tm, only 12 of the 22 antagomir nucleotides were
blocked from let-7 miRNA binding.

B. Photoactivatible miRNA antagomir: CHANT2
A second caged hairpin antagomir, CHANT2 (Figure 2-5B), was developed with
the goal of minimizing background miRNA binding pre-photolysis, while maximizing
miRNA binding post-photolysis. To achieve these aims, we reasoned that the caged
hairpin must form a longer, stable duplex structure prior to irradiation, and become less
thermodynamically stable afterwards. In particular, the high melting temperature of
CHANT1 post-photolysis indicated a route to further optimization.
To minimize caged antagomir background activity, the number of complementary
bases in the blocking sequence was increased such that fewer antagomir bases were
available to bind to the miRNA. By adding an additional photocleavable moiety in the
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blocking strand, it was possible to incorporate more bases within the blocking strand,
without sacrificing antagomir activity after irradiation. Prior to in vivo studies, one goal
in design optimization was to increase ∆Tm, pre- vs. post-photolysis.
The same 22-mer antagomir complementary to let-7 miRNA was covalently
attached via a PL to a blocking strand comprised of a 9-mer and 10-mer linked by an
additional PL (Figure 2-5B). This PL blocking strand design was guided by our
previously published RNA “bandage" which used two shorter sequences linked by a PL
to achieve mRNA blocking pre-photolysis and dissociation post-photolysis.36 Consistent
with successful RNA bandage designs,36 a one nucleotide gap was introduced at the
position of the PL. Finally, because terminating the blocking sequence with a guanine or
cytosine base should result in a more stable duplex, the blocking strand was extended by
one base on the 3′ end to a 10-mer to facilitate G/C base-pair termination.
CHANT2 was synthesized on solid support, purified by HPLC (Figure 2-2, Table
2-1) and the mass was confirmed by MALDI-TOF MS (Table 2-3, Figure 2-4). The ∆Tm
for CHANT2 was measured to be -38 °C: Tm (-UV) = 71 °C, Tm (+UV) = 33 °C (Figure 2-8).
Significantly, Tm (+UV) was much closer to rt than observed for CHANT1, which should
improve the miRNA-binding activity of the uncaged antagomir. Moreover, relative to
CHANT1 with a single 12-mer blocking strand, CHANT2 exhibited a significantly
greater difference in thermal stability pre- vs. post-photolysis, ∆∆Tm = 17 °C.
Interestingly, Tm

(-UV)

was significantly lower for CHANT2 than CHANT1, which

indicates that the 9-mer-PL-10-mer blocking strand did not behave as a contiguous 1962

mer. This is likely due to the intervening PL, and also the one nucleotide gap included in
the 9-mer-PL-10-mer design. This is further corroborated by the appearance of the broad
Tm curve. Upon photolysis, two short oligonucleotides of different lengths will dissociate
at different temperatures, causing the melting curve to broaden.
Based on Tm alone, it would appear as though CHANT1 would be more stable
prior to photolysis due to a higher melting temperature. However, when the structure of
CHANT2 is taken into account and analyzed together with in vivo data, it is clear that
thermal stability alone is not a clear predictor of blocking efficiency. In cases where the
Tm is significantly above incubation temperature, it is expected that the hairpin will
remain annealed. A more important factor becomes the antagomir bases that are sterically
blocked when the caged hairpin is fully annealed, and this is why the addition of the
second PL becomes so critical for in vivo efficiency. Preliminary in vivo studies were
performed by co-injecting a 10 µM solution of let-7 miRNA with varying concentrations
(30 – 100 µM) of CHANT2 into embryos at the 1-cell stage. CHANT2 at 50 µM
exhibited high activity with minimal toxicity. Thus, a 10 µM solution of let-7 miRNA
and 50 µM CHANT2 was subsequently injected into all zebrafish embryos at the one-cell
stage. Half of the injected embryos were incubated at 28 °C in the dark, while the other
half were irradiated at 1 hpf for 10 min with the near-UV transilluminator. The embryos
were incubated for 24 h in the dark at 28 °C and then imaged to determine phenotypic
response (Figure 2-9). The embryos that were irradiated (n = 40) developed normally
which clearly showed that the uncaged antagomir was active. Photoactivated CHANT2
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rescued the normal wildtype phenotype for nearly 90% of zebrafish embryos, vs. 80% for
CHANT1 embryos (Figure 2-10). A marked improvement was also seen in antagomir
caging in the non-irradiated embryos (n = 45), with just 2% background activity for
CHANT2 compared to 20% for CHANT1 (Figure 2-10). This 2% background can be
attributed to injection error, which can range from 0 - 10% of embryos. This construct
was also tested at lower concentrations (30 - 50 µM) and it was demonstrated that in vivo
efficiency is dependent on concentration. This concentration dependence is expected, as
the amount of free antagomir post-photolysis directly depends on the incubation
temperature (28°C) which happens to be below the Tm. The concentration reported with
maximum efficiency is far below 100 µM, the concentration where significant toxicity
was observed.
The significant decrease in CHANT2 background activity as compared to
CHANT1 highlights that the 9-mer-PL-10-mer blocking strand caged the antagomir more
effectively than the original 12-mer, despite the lower thermal stability of CHANT2 (Tm
= 72 °C) relative to CHANT1 (Tm
for CHANT1 is reported as

85 °C) (Figure 2-6, 2-8). The melting temperature

85 °C as the exact temperature cannot be determined since

a full transition cannot be observed at such a high Tm. The data indicate that CHANT2 is
nearly optimized for photomodulating the let-7 antagomir in the current experimental
paradigm, where miRNA is co-injected in zebrafish embryos.
With the creation of CHANT1 and CHANT2 and the two previously published
caged antagomirs,19,37 a new class of tools for downregulating miRNA with light is
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emerging. Connelly et al. presented an elegant method of caging antagomirs miR-122 and
miR-21 with minimal background activity and showed efficient antagomir restoration
post-photolysis, however, this involved the use of custom caged bases. Zheng et al.
presented the first example of in vivo miRNA photomodulation by using a caged hairpin
antagomir. To achieve very efficient caging and uncaging, it was necessary to design and
test a large number of caged antagomirs. Our CHANT2 design minimizes the need for
optimization, as the second PL allows a much larger portion of the antagomir to be
blocked without sacrificing uncaging efficiency. This will facilitate the targeting of
multiple miRNAs without optimization necessary for each sequence. Additionally, the
commercial availability of the 2′-OMe RNA phosphoramidites and PL used in CHANT2
make it readily accessible to biological researchers.
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Figure 2-5. Structures of caged hairpin antagomirs CHANT1 and CHANT2.
A) CHANT1: A 22-mer miRNA antagomir targeting let-7 miRNA was covalently attached to a
complementary 12-mer blocking sequence via a nitrobenzyl photocleavable linker, PL (in red).
Upon photolysis, the 12-mer more readily dissociated, restoring antagomir function. B)
CHANT2: A 22-mer miRNA antagomir targeting let-7 miRNA was covalently attached to a 5′-9mer-PL-10-mer blocking sequence. Upon PL photolysis, antagomir function was restored. All
sequences consisted of 2′-OMe RNA bases.
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Figure 2-6. Melting temperature data for CHANT 1.
Melting temperature analysis of CHANT1 showing a Tm of 85 °C prior to photolysis, and 64
°C post-photolysis, decreasing the melting temperature (∆Tm) by at least 21 °C
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Figure 2-7. CHANT1 in vivo experiments.
A) Embryos injected at the 1-cell stage with 10 M let-7 miRNA showed let-7 early induction
phenotype. B) Embryos injected with 10 µM let-7 miRNA + 50 µM CHANT1 showed similar
let-7 early induction phenotype prior to 365 nm irradiation. C) Embryos injected with 10 µM let7 miRNA + 50 µM CHANT1 developed normally after 365 nm irradiation for 10 min at 1 hpf.
All embryos were imaged at 24 hpf.
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Figure 2-8. Melting temperature data for CHANT2
Melting temperature analysis of CHANT1 showing a Tm of
°C prior to photolysis, and 33 °C
post-photolysis, decreasing the melting temperature (∆Tm) by 38 °C.
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Figure 2-9. CHANT2 in vivo experiments.
A) Embryos injected at the 1-cell stage with 10 M let-7 miRNA showed let-7 early induction
phenotype. B) Embryos injected with 10 µM let-7 miRNA + 50 µM CHANT2 antagomir showed
let-7 early induction phenotype prior to 365 nm irradiation. C) Embryos injected with 10 µM let7 miRNA + 50 µM CHANT2 developed normally after 365 nm irradiation for 10 min at 1 hpf.
All embryos were imaged at 24 hpf.
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Figure 2-10. CHANT1 vs. CHANT2 in vivo efficiency.
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C. Caged circular miRNA, CIRClet7
In addition to the caged hairpin antagomirs, which provide a method to “turn off”
miRNA with light, caged circular let-7 miRNA (CIRClet7) was designed to “turn on”
exogenous miRNA with light. The circular design provides a way to introduce miRNA
into a biological system and subsequently activate at the desired place and time by
irradiating with 365 nm light.
Similar to the caged antagomirs, this caged miRNA uses fully 2′-O-methylated
bases to limit degradation that is problematic with unmodified RNA. A complementary
22-mer 2′-OMe RNA miRNA and blocking strand were synthesized containing two PLs,
a free amine on the 3′ end, and a disulfide on the 5′ end as shown in Figure 2-11. The 5′
and 3′ ends were linked together in a "circularization reaction" by first reacting the
succinimide of a commercially available heterobifunctional linker with the 3′-amine. The
5′-disulfide was then reduced with TCEP, allowing subsequent reaction with the linker
maleimide and resulting in a circularized oligonucleotide. Both the linear and circularized
oligonucleotides were purified by HPLC (Figure 2-3, Table 2-2). Upon photolysis, the
circular miRNA was linearized as shown in Figure 2-11. The phosphate group revealed
on the 5' end of the biologically active miRNA allows for processing by the multi-protein
RNA-induced silencing complex (RISC). Our lab’s previous circular design for caged
DNAzymes used Circligase for circularization, which limited the reaction to the picomole
scale.38 By using the heterobifunctional linker, more oligonucleotide can be circularized
in a single reaction. Circularization yield, calculated from gel band intensity, was
72

determined to be 45% when performed on a 1 nmol scale (Figure 2-12). Additionally, a
method was developed to purify the circular construct by HPLC without having to do
lengthy gel extractions to remove linear starting material. Purity was confirmed by a
well-resolved product peak on HPLC which was further analyzed using gel
electrophoresis (Figures 2-3B, 2-12).
To test this circular miRNA in vivo, a 20 µM solution of CIRClet7 was injected
into zebrafish embryos at the one-cell stage. Half of the injected population was
incubated in the dark at 28 °C (n = 18). The other half was irradiated with 365 nm light
for 10 min at 1 hpf before incubation (n = 21). The embryos were analyzed and imaged at
24 hpf for phenotypic response. As shown in Figure 2-13, embryos injected with the
caged miRNA developed normally, while embryos injected and irradiated developed with
the let-7 miRNA early induction phenotype. These results were seen in 100% of embryos
injected, indicating that there was no background activity prior to photolysis and
uncaging completely restored miRNA activity. Interestingly, the phenotype induced by
the 2′-OMe RNA circular design varies slightly from the phenotype induced by the let-7
miRNA. A 2′-OMe RNA control miRNA was injected into zebrafish embryos (Figure 214) to confirm that this was not a result of the circular construct, but rather a result of an
analog used to induce the miRNA phenotype.
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Figure 2-11. Synthesis and photocleavage of circular caged miRNA (CIRClet7)
A photocleavable oligonucleotide duplex with 3′-amine and 5′-thiol was circularized with a
heterobifunctional crosslinker. The crosslinker was first reacted with the 3′-amine, and
circularization proceeded after 5′ disulfide reduction with TCEP. Upon photolysis, the active
miRNA strand was released with a 5′-phosphate for processing by RISC.
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Figure 2-12. Gel electrophoresis of CIRClet7 crude reaction mixture and CIRClet7 after
HPLC purification.
A) Gel after CIRClet7 circularization procedure used to calculate circularization yield by band
intensity. ImageQuant TL 7.0 was used for band quantification using the rubber band subtraction
method. Circularization yield was calculated to be 45%. B) Gel after HPLC purification of
CIRClet7 showing only circularized product. All gels were cast using 20% polyacrylamide and 7
M urea and run at 300 V for 45 min. Gels were stained with ethidium bromide.
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Figure 2-13. CIRClet7 in vivo experiments.
A) Zebrafish embryos injected with 20 µM CIRClet7 and incubated in the dark developed
normally. B) Embryos irradiated with 365 nm light developed with the early induction let-7
miRNA phenotype. All embryos were imaged at 24 hpf.
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Figure 2-14. Comparison of control, RNA-induced phenotype, and 2′-OMe RNA-induced
phenotype.
A) Uninjected control embryo imaged at 24 hpf showing normal development. B) Embryo
injected with 15 µM let-7 2′-OMe RNA showing a variation of the let-7 early induction
phenotype. C) Embryo injected with 10 µM let-7 RNA showing a variation of the let-7 early
induction phenotype.
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IV. Conclusion
miRNAs are an abundant class of small gene-regulating RNAs, and our
understanding of their diverse biological functions is still incomplete. New chemical
tools, such as those introduced here, will make it possible to probe how each miRNA
regulates a multitude of genes in different locations and at different times in vivo.
A set of caged antagomir and caged miRNA constructs have been designed with
the ability to regulate miRNA from "on to off" as well as "off to on" with light. These
tools were shown to control exogenously supplied miRNA and have the potential to
control endogenous miRNA as well. These caged constructs are effective in zebrafish
embryos and could readily be optimized for use in other model organisms, such as
Xenopus39 and C. elegans.6,8 By using 2′-OMe RNA oligonucleotides, the synthesis of
these constructs was greatly simplified, as these analogs can be prepared very
successfully on solid support using commercially available phosphoramidites.
Two caged antagomir designs were designed, CHANT1 and CHANT2. With the
addition of the second photocleavable linker in CHANT2, more antagomir bases were
sterically blocked prior to irradiation without sacrificing antagomir activity postphotolysis. With the addition of a second PL, the blocking strand could be lengthened to
diminish background activity seen in the first design. Previously, our lab described
several examples of caged antisense hairpins with a similar design to CHANT1 using
only one PL.22,35 Based on this current study, it appears beneficial to incorporate a second
PL in many caged hairpin constructs.
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To introduce an exogenous miRNA and provide a method for turning a miRNA
from "off to on", a circular caged miRNA was designed. CIRClet7 is the first example of
a caged miRNA, and was demonstrated in a zebrafish model system. As not all
developmental programs stem from the downregulation of a miRNA, it is also useful to
have a tool to probe the effects of miRNA upregulation in different systems. The tools
described herein will provide new ways to probe miRNA function, which until now has
been difficult to resolve with loss-of-function experiments. A direct follow-up to this
work could be the use of light-activatible probes to determine more precisely the genes
on which let-7 miRNA acts in different locations and times in early embryo development,
as it is known that there are multiple targets.5 While these constructs have been
developed specifically for let-7 miRNA in zebrafish, these methods can very easily be
applied to additional miRNAs in various biological systems.
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I. Introduction
Photochemical methods for regulating the structure, function, and/or localization
of molecular species provide a powerful toolkit for manipulating advanced materials as
well as complex biological systems. For example, channelrhodopsin—a single
component, light-activated cation channel protein from algae—was co-opted in the
development of pioneering optogenetic approaches for manipulating the activity of
specific neurons and controlling animal behavior.1 More generally, “caged” molecules,2
whose latent biological activity can be revealed with light, have been widely adopted,
particularly for the study of amino acids,3 peptides,4 neurotransmitters,5 and metal ions.6
In each case, photoactivation with high spatiotemporal control can be achieved using a
focused laser beam of suitable wavelength. Less investigated are caged oligonucleotides,
despite the central roles played by DNA and RNA in Biology, and the tantalizing
potential for being able to turn genes “on” or “off” with light. Synthetic challenges of
site-specifically incorporating one or more photolabile moieties within a large
oligonucleotide, and limitations arising from the available near-UV-activatible caging
moieties, have slowed the development of such oligos.
A particular focus for caged oligo development has been antisense morpholinos,
which are commonly used to block mRNA translation and modify pre-mRNA splicing in
a variety of model organisms, including mouse, zebrafish, frog, sea urchin, and chick.7
Morpholino antisense oligos are also being investigated for therapeutic applications in
humans. Robust methods for photoregulating MO antisense knockdown should enable
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the study of multiple, in vivo gene functions at specific locations and times, while also
reducing the potential for systemic toxicity.
Initial caged antisense oligos from our lab8-10 and the Chen lab11-13 employed
DNA hairpin-like designs with the antisense oligo conjugated to a shorter,
complementary sense strand via a photocleavable linker. Deiters et al. subsequently
presented caged morpholinos where multiple photocaged nucleotide monomers were
incorporated during solid-phase synthesis.14 In this example, morpholino-mRNA
hybridization was sterically blocked until the caging groups were released from the
nucleobases.14 A newer design strategy, presented by Yamazoe et al.,15 Wang et al.,16 and
Wu et al.,17 has involved "circularizing" the oligonucleotide, by attaching the 5′ and 3′
ends with a photocleavable linker. The covalent linkage enforces the closed circular
conformation, which prevents efficient MO hybridization to target mRNA; photocleavage
restores the linear, biologically active MO. All of these approaches have employed a
photocleavable linker, such as o-nitrobenzyl or hydroxycoumarin, which yields optimally
to near-UV irradiation.18
To expand in vivo applications using caged oligos, there is need for synthetically
versatile photolinkers that can be activated at visible or near-IR wavelengths as near-UV
light has poor tissue penetration and can be toxic at high exposure levels.19-21 Previous
strategies include the use of near-IR-to-UV upconversion nanoparticles to achieve siRNA
photoactivation in cells and tissues,20 however, this approach limits the potential for
multiplexing experiments involving two (or more) orthogonally caged compounds.
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Recently, Yamazoe et al. presented a 465 nm activatable coumarin derivative for MO
caging.22 Here, we exploit versatile ruthenium photochemistry to achieve caged oligos
that are efficiently activated with visible light.
Ruthenium complexes of the general type [Ru(bipyridine)2(X)2]2+, where X =
amine,23 nitrile,24 pyridine,25 or thioether26 ligands, have been shown to undergo facile
ligand exchange with solvent upon irradiation with visible one-photon or near-IR twophoton excitation.1,27 Biologically active small molecules can be directly ligated to the
Ru2+ center, and then released with visible light.27 In 2003 Etchenique and coworkers
first applied this Ru-ligand exchange property by caging a potassium channel blocker, 4aminopyridine,25 and have since caged several neurotransmitters.23,28,29 More recently,
Turro’s lab has investigated the ruthenium polypyridyl complexes for their potential as
photodynamic drugs.4,9 Building on these and other Ru-caging examples,3,12,28,30-32 we set
out to develop a Ru-photolinker amenable to caging oligos and other large biomolecules,
with the goals of bypassing the harsh synthetic conditions typically required for ligand
substitution at Ru2+, and avoiding direct reaction between biomolecules and Ru2+.
Here, we report the synthesis, characterization, and application of the first Ruphotolinker, [Ru(bipyridine)2(3-ethynylpyridine)2]Cl2 (RuBEP) (Scheme 3-1). The bisalkyne functionality enabled circularization of an oligonucleotide containing azides at
both 5′ and 3′ termini via [3+2] azide-alkyne copper(I)-mediated cycloaddition
reactions.33,34 In this way, the octahedral Ru2+ center remained coordinatively saturated,
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and side-reactions between Ru2+ and the nucleobases were avoided. Photolysis at 450 nm
restored the linear, biologically active oligo (Scheme 3-1).

II. Experimental procedures

A. Synthesis of [Ru(bpy)2(3-ethynylpyridine)2](PF6)2 (RuBEP)
Ru(bpy)2Cl2 (101.8 mg, 0.20 mmol) and AgSO3CF3 (105 mg, 0.41 mmol) were
suspended in distilled methanol (10 mL). Solution was placed in the freezer overnight
under nitrogen. The solution was then brought to rt, filtered to remove AgCl, and 3ethynylpyridine (3EP, 201.7 mg, 0.40 mmol) was added. The reaction was heated to 75
o

C for 5 h until no further changes were observed by UV-Vis spectroscopy (Figure 3-1).

The methanol was removed under reduced pressure and product was redissolved in
boiling water. Solid ammonium hexafluorophosphate was added to the chilled solution
until a light orange precipitate was formed. This was vacuum filtered, washed twice with
cold water and dried. Compound was further purified by 1.5 x 15 cm silica column (230400 mesh) with 9:1 dichloromethane:acetonitrile as eluent and isolated in 71% yield
(106.6 mg, 0.12 mmol). The water-soluble chloride salt was synthesized by addition of
tetrabutylammoniom chloride to a solution of [Ru(bpy)2(3EP)2][PF6]2 dissolved in
acetone. The synthetic scheme is shown in Scheme 3-2.
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1

H NMR (500 MHz, CD3CN) 3.74 (s, 1H, 3EP-H5), 7.33 (dd, 1H, J = 7.9, 3EP-H3), 7.39

(ddd, 1H, J = 6.7, bpy-H3), 7.82 (ddd, 1H, J = 6.4, bpy-H6), 7.90 (d, 1H, J = 5.4, bpy-H1),
7.95 (dd, 1H, J = 5.8, 3EP-H2), 7.97 (dd, 1H, J = 7.6, bpy-H2), 8.19 (td, 1H, J = 7.9, bpyH7), 8.31 (d, 1H, J = 8.2, bpy-H4), 8.32 (d, 1H, J = 5.2, 3EP-H1), 8.38 (s, 1H, 3EP-H4),
8.40 (d, 1H, J = 7.9, bpy-H5), 8.95 (d, 1H, J = 5.2, bpy-H8).

13

C NMR (500 MHz, CD3CN) 78.8, 84.5, 122.8, 124.9, 125.2, 126.9, 128.7, 129.0,

138.9, 139.2, 142.1, 153.5, 153.7, 154.5, 156.5, 158.6, 158.7.
Anal. Calc. for C34H12N6RuP2F12: C, 65.90; H, 4.23; N, 13.56. Found: C, 66.2; H, 4.30;
N, 13.7. MS(ES): m/2z 310.06, expected: m/2z 310.06

B. Circularization procedure for DNA and morpholino
Reactions were performed on a 10 - 12 nmol scale. Mono-azido DNA and bisazido DNA was purchased from Integrated DNA Technologies, Coralville, Iowa. Bisazido morpholinos (Figure 3-2) were custom ordered from GeneTools, Philomath,
Oregon. Bis-azido oligonucleotides were premixed with RuBEP at the indicated
stoichiometric ratios. Cu(I)Br was dissolved in 3:1 DMSO/t-butanol to make a 0.1 M
solution. TBTA ([(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine) (Anaspec, Freemont,
CA) was dissolved in 3:1 DMSO/t-butanol to make a 0.1 M solution. Cu(I)Br and TBTA
were mixed in a 1:2 ratio and preincubated. The azide/alkyne solution volume was
adjusted to 25 µL (for morpholino reactions) and 50 µL (for DNA reactions). 12% v/v of
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the Cu(I)Br/TBTA solution was added to the oligonucleotide solution. Table 3-1 shows
relative stoichiometries for click reactions. Solutions were sparged with N2 and sealed
tightly with parafilm. Reactions proceeded for 3 h (DNA) and 24-48 h (MO).
Temperatures varying from RT to 55 °C were tested, and no significant correlation was
found between temperature and product formation. Additionally, vortexing or not mixing
did not seem to change product formation. After reaction completion, a NAP-5 desalting
column (GE Healthcare) was used to remove unreacted RuBEP, Cu(I)Br, and TBTA.
Circular product was stored in aqueous solution at -20 °C.

Table 3-1. Stoichiometries for DNA and MO circularization reactions

Reagent

nmol

Azido-oligo

10 - 12 nmol

RuBEP

10.0

Cu(1)Br

100.0

TBTA

200.0

C. HPLC purification for N3-DNA, Ru-DNA, N3-DNA-N3, and Ru-cDNA
A gradient of increasing acetonitrile in 0.05 M triethylammonium acetate in H2O
was used with a Zorbax reverse-phase C18 column (Table 3-2). The column was heated
to 40 °C during purification. Product elution times are indicated on HPLC traces (Figure
3-3). All purifications were performed on an Agilent 1200 Analytical HPLC using a
diode-array detector at 260 nm.
89

D. Gel-shift assay and PAGE analysis
DNA constructs (25 pmol) were analyzed on 15 % or 20% polyacrylamide, 7M
urea gels using Ambion Loading Buffer II (Invitrogen, Grand Island, NY). Gels were run
at 300 V for 45 min and stained for 15 minutes with EtBr. Gels were imaged with a
Typhoon FLA 7000 imaging system (GE Healthcare Life Sciences, Pittsburgh, PA).
Morpholino constructs (25 pmol) were analyzed using a gel-shift assay. 15% or
20% polyacrylamide, native gels were run with NativePAGE Sample Buffer (4x)
(Invitrogen, Grand Island, NY). Running buffer (1X TBE) was cooled to 10 °C on ice
and cast gel was preincubated in cold buffer before loading. Samples were prehybridized
by heating to 80 °C for 40 minutes and immediately cooled in an ice bath for 10 min.
Gels were run in an ice bath for 120 min at 100 V and subsequently stained for 15
minutes with EtBr. Gels were imaged with a Typhoon FLA 7000 imaging system (GE
Healthcare Life Sciences, Pittsburgh, PA).

E. Light Sources
A Luxeon III Star® Royal Blue© LED was used for uncaging experiments,
purchased from Quadica Developments Inc. (Ontario, Canada). Power measured at the
sample was 14 mW/cm2 with a maximum output wavelength of 450 nm.
A Sapphire Galaxy Blue handheld laser was purchased from Beam of Light
Technologies (Oregon, USA) and used to determine the quantum yield of RuBEP. Power
measured at the sample was 53 mW/cm2, with a maximum output wavelength of 450 nm.
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F. Molecular beacon hybridization assay
A molecular beacon complementary to bis-azido oligo sequence was designed,
with fluorophore, 6-FAM on the 5′ end, quencher, BHQ1 on the 3′ end and a 6-nt
complementary stem (Table 3-7). Caging was monitored by the opening of the molecular
beacon in the presence of oligonucleotide. Circular oligo was hybridized to the molecular
beacon, excited at 494 nm, and fluorescence intensity at 523 nm was quantified. For
comparison, the fully complementary linear bis-azido oligo as well as a mismatch
sequence, were also monitored. The circular oligo was then exposed to 450 nm light (3
min 14 mW/cm2), and rehybridized to the molecular beacon. All solutions were made to
1 pmol/µL with a 50 µL volume. All samples were prehybridized prior to analysis, by
heating to 80 °C for 30 min, and immediately incubated on ice for 10 min. Samples were
analyzed at 10 °C.

Table 3-2. Gradient used for Ru-DNA and Ru-cDNA HPLC purification

Time (min)
0.0
40.0
50.0

% Acetonitrile
90
40
20

% 0.05 M TEAA
10
60
80

G. Zebrafish microinjection experimental details
Zebrafish embryos were obtained from the CDB Zebrafish Core Facilty at the
University of Pennsylvania Perelman School of Medicine. All embryos obtained were
TLF x TLF (WT). Zebrafish embryo injection solutions were prepared to contain a final
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concentration of 0.1 M KCl and 0.25% phenol red dye. All injections were performed at
the one-cell stage and injected into the cell compartment only. A Harvard Apparatus PLI100 pico-injector was used to inject controlled volumes. Injection volume was calibrated
to dispense 5 nL per embryo. Zebrafish embryos were incubated at 28 °C in E3 zebrafish
medium. All embryos were incubated in the dark, except for irradiated samples, which
were exposed to 450 nm light (14 mW/cm2) for the stated time and returned to the dark
incubator. Embryo micrographs were collected at 24 hpf with an Olympus FV1000 laser
scanning confocal microscope using transmitted light imaging. A 10x air objective was
used for single embryo imaging and 4x air objective was used for multiple embryo
imaging.

H. Materials
Organic reagents and solvents were used as purchased from the following
chemical sources: Methanol, methylene chloride (HPLC grade), acetonitrile (HPLC
grade), and acetone were purchased from Fisher Scientific. Cis-dichloro-bis(2,2’bipyridine)ruthenium(II) (98%), 3-ethynylpyridine (96%), silver trifluoromethansulfonate
(99+%),

ammonium hexafluorophosphate (99.5%), acetonitrile-d3 (99.8 atom%),

tetrabutylammonium chloride hydrate (98%), deuterium oxide (99.8 atom%) were
purchased from Acros Organics.
Complementary DNA oligonucleotides, azido-DNA oligonucleotides, and
molecular beacons were custom synthesized and HPLC purified by Integrated DNA
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technologies (Coralville, IA). Azido-MOs were custom synthesized by Gene Tools
(Philomath, Oregon). All gel reagents were purchased from Bio-Rad (Hercules, CA).
TBTA

ligand

(Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine)

was

purchased

through Anaspec (Fremont, CA). Zebrafish embryos were obtained through the CDB
Zebrafish Core Facilty at the University of Pennsylvania Perelman School of Medicine.

I. Instrumentation
A Luxeon III Star® Royal Blue© LED was used for uncaging experiments postclick reactions, including in vivo work. It was purchased from Quadica Developments
Inc. (Ontario, Canada) with a maximum output wavelength of 450 nm. Measured power
at sample was 14 mW/cm2.
A sapphire Galaxy Blue handheld laser was purchased from Beam of Light
Technologies (Oregon, USA) and used to determine the quantum yield of RuBEP.
Measured power at the sample was 53 mW/cm2, with a maximum output wavelength of
450 nm.
UV-Visible spectroscopy was performed using an Agilent 8453 UV-Visible
spectrometer (Agilent Technologies, Germany) in water unless otherwise specified. 1H
NMR spectra were obtained on a Bruker DMX 500 spectrometer, and

13

C NMR spectra

were obtained using a Bruker AVIII cryo500 probe spectrometer at the University of
Pennsylvania NMR facility and were recorded at room temperature. The 1H and

13

C

spectra were referenced to the central line of the solvent residual or to TMS at 0.00 ppm.
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1

H NMR and 13C NMR chemical shifts () are given in parts per million and reported to a

precision of ± 0.01 and ± 0.1 ppm, respectively. Proton coupling constants (J) are given
in Hz and reported to a precision of ± 0.1 Hz.
High-resolution mass spectra (HRMS) were obtained using electrospray
ionization (ESI) mass spectrometry on a Micromass Autospec at the Mass Spectrometry
Facility in the Department of Chemistry at the University of Pennsylvania. Irradiated
sample was analyzed via direct infusion nanospray with a Thermo ORBI trap XL mass
spectrometer at 60 K resolution. Gels were imaged with a Typhoon FLA 7000 imaging
system (GE Healthcare Life Sciences, Pittsburgh, PA).
All purifications were performed on an Agilent 1200 Analytical HPLC using a
diode-array detector set to 260 nm. A 5-micron Zorbax semi-preparatory C18 column
(9.4 x 215 mm) was used for all reverse-phase purifications.
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Scheme 3-1. RuBEP conjugation and irradiation
Photolinker RuBEP conjugation with 25mer bis-azido morpholino to form “caged” antisense MO.
1,4-regioisomers of 1,2,3-triazoles are the sole product of the copper(I)-catalyzed azide-alkyne
cycloaddition (CuAAC). Subsequent 450-nm irradiation restores biologically active MO.
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Scheme 3-2. Synthetic scheme of RuBEP
RuBEP was synthesized from Ru(bpy)2Cl2 via a two-step synthesis.
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Figure 3-1. UV/Vis monitoring product formation
UV-Vis spectra of RuBEP synthesis reacted in methanolat75 oC. The peak at 520 nm was due to
Rubpy2OTf, which disappeared as RuBEP was formed to give the double peak near 450 nm.
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Figure 3-2. Structure of bis-azido morpholino
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Figure 3-3. HPLC traces for N3-DNA.
A) N3-DNA eluted at 25.0 min and B) Ru-DNA after click reaction eluted at 22.3 and 24.1 min
using gradient shown in Table 3-2.
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Figure 3-4. HPLC traces for N3-DNA-N3
A) N3-DNA-N3 eluted at 27.5 min and B) Ru-cDNA after click reaction eluted at 22.5 min using
gradient shown in Table 3-2.
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III. Results and Discussion

A. RuBEP
The RuBEP photolinker was synthesized from Ru(bpy)2Cl2 and 3-ethynylpyridine
(3EP) by modifying a published procedure.9 Reaction progress was monitored by the
appearance of an MLCT band at 450 nm (Figure 3-1). Precipitation with
tetrabutylammonium chloride produced the water-soluble chloride salt, RuBEP, which
was characterized by X-ray crystallography (Appendix A), ESI-MS (Figure 3-6), 1H and
13

C NMR (Figure 3-7), and elemental. X-ray crystallography revealed a 92° angle

between alkyne linkers, confirming correct geometry for circularization applications
(Figure A1-1).
Photodissociation of the 3-ethynylpyridine ligand from RuBEP was monitored by
LCMS (Figure 3-6), UV-Vis (Figure 3-5) and NMR (Figure 3-7) spectroscopies. Upon
continuous irradiation of RuBEP in water with 450 nm light (53 mW/cm2), the λmax redshifted from 450 nm to 473 nm (Figure 3-5). Photolysis of the bulk RuBEP solution (80
µM) was detectable within the first 20 s, with complete dissociation in 5 min. In addition
to the wavelength shift, a very obvious color change was also present, as shown in Figure
3-5, inset. The orange photo-product ([Ru(bpy)2(3EP)(OH2)]2+) was consistent with
previously characterized [Ru(bpy)2(pyr)(OH2)]2+ complexes.35 Two isosbestic points
were observed (Figure 3-5), consistent with the exchange of one ligand for a solvent.24
1

H NMR also showed the exchange of only one 3EP ligand with a solvent water
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molecule, based on an observed shift in alkyne peak and change in integration (Figure 37). HR-MS also confirmed the photoproduct assignment with a mass change from 620 Da
to 552 Da (Figure 3-6).
To probe toxicity of RuBEP in vivo, 1-cell stage zebrafish embryos were
microinjected with 1 mM RuBEP and subjected to either 450 nm light (14 mW/cm2, 5
min), or incubated in the dark. Concentrations for in vivo experiments are significantly
lower than this concentration, typically 0.1 - 0.5 mM. Both batches of embryos were
observed to remain healthy and develop normally, whether incubated in the dark or
irradiated with visible light, and survival rates were comparable to the uninjected control.
To determine the efficiency of ligand exchange, the quantum yield in water under
ambient oxygen (φ= 0.33 +/- 0.06) was determined by fitting the initial kinetics of the
photoreaction (Figure 3-8). The quantum yield for RuBEP was determined to be
comparable

to

the

quantum

yield

of

ligand

exchange

measured

for

Ru(bpy)2(pyridine)2Cl2, showing that the electronics of the added alkyne does not have
much effect on the efficiency.25 The uncaging efficiency for RuBEP—defined as ε450
times φ—was determined to be 2.0 x 103 M-1cm-1 at 450 nm, which is much higher than
measured for typical organic chromophores activated at near-UV wavelengths.
Commonly used nitrobenzyl derivitives, such as the o-nitrobenzyl caging group used in
previous caging methods in our lab have 1-P uncaging efficiencies less than 100 M-1cm-2
at 365 nm.4,36
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B. Ru-cDNA
Initial efforts in circularization were focused on using a DNA oligonucleotide.
Although DNA does not have antisense activity in zebrafish embryos, the use of DNA
allowed for proof-of-concept experiments and protocol development due to ease of
solubility and ability to purify using reverse-phase HPLC. Using RuBEP as photolinker,
circularization protocols were initially investigated using a bis-azido 25mer DNA
oligonucleotide.
The [3+2] Cu(I)-mediated cycloaddition reaction was performed at a
stoichiometry of 1.2 DNA:1 RuBEP, and monitored by polyacrylamide gel
electrophoresis. A time-course gel was used to follow reaction progression and product
formation. A band migrating faster than the bis-azido DNA appeared within the first 15
min of reaction (Figure 3-9). A faster migrating band is consistent with circularization, as
a more compact, circular structure would have this effect. Additionally, the positive
charge contributed by RuBEP could also play a role in gel migration speed. To confirm
that this was the Ru circularized DNA (Ru-cDNA) and not RuBEP clicked to two linear
DNA oligos (DNA-RuBEP-DNA), a mono-azido DNA was subjected to the same
reaction conditions, which resulted in a slower migrating band (Figure 3-10).
In addition to circular product, formation of polymer and dimer also occurred.
This is especially apparent with the bis-azido DNA (Figure 3-9, lanes 2-3), which is
expected due to the two azides. Although the 1.2:1 DNA to RuBEP stoichiometry should
favor only one linker per oligo and subsequent circularization, other 1:1 structures could
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form as well such as Ru-DNA-Ru-DNA, and an equal combination of RuBEP-DNARuBEP and DNA-RuBEP-DNA. These side products became less apparent on the gel
after the first 30 minutes of reaction (Figure 3-9) which is likely because these RuBEPDNA polymers were less soluble and didn't remain in solution with extended reaction
times. The mono-clicked product is visible on the gel in the first 15 minutes (Figure 3-9,
Lane 2), showing that initially one side reacts, and then due to stoichiometry and
concentration favoring circularization, an intramolecular reaction occurs. As expected,
significantly less polymer formation was formed with the mono-azide DNA reaction than
with RuBEP (Figure 3-10, Lane 2). A secondary band migrating slower than the linear
Ru-DNA was the only significant side product, likely a DNA-RuBEP-DNA dimer due to
the presence of two alkynes on RuBEP.
The reaction products for both the Ru-cDNA and Ru-DNA were readily isolated
by reverse-phase HPLC (Figures 3-3 A-B, Table 3-2). The retention times for the monoazide and bis-azido DNA differed by 2.5 min (25.0 vs 27.5 min for mono- vs. bis-azido
DNA). However, retention time for both Ru-DNA and Ru-cDNA were both very similar
(22.3 vs 22.5 min for Ru-DNA vs Ru-cDNA). These two constructs are very similar in
many aspects such as hydrophobicity, charge, and molecular weight, making HPLC
separation very challenging with reverse phase and ion-exchange methods. To
circumvent this, reaction conditions were optimized so that no Ru-DNA remained in the
Ru-cDNA reaction. The Ru-cDNA and Ru-DNA could be readily separated from other
reaction products using reverse-phase HPLC. Figure 3-11 shows successful isolation of
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pure Ru-cDNA after HPLC purification. Circularization occurred with greater than 80%
efficiency (determined by gel band intensity quantification) and approximately 25% was
recovered after HPLC purification.
To probe circularization and caging, a molecular beacon (MB) complementary to
the N3-DNA-N3 sequence was designed with fluorophore 6-FAM on the 5′ end and
quencher BHQ1 on the 3′ end, with a 6-nt complementary stem (Table 3-7). A calibration
curve was made with DNA:MB ratios of 0:1 to 5:1 to confirm opening of the molecular
beacon with complementary bis-azido DNA (Figure 3-12). With RuBEP holding the
25mer DNA in a circular conformation, the ability to fully hybridize to a complementary
DNA is hindered. Four different conditions were tested. MB with a scrambled sequence
MB with a fully complementary bis-azido linear sequence, MB with Ru-cDNA, and MB
with Ru-cDNA exposed to 450 nm (14 mW/cm2, 5 min) (Table 3-7). Caging, indicative
of circularization, was monitored by the opening of the molecular beacon in the presence
of oligonucleotide. Ru-cDNA was hybridized to the molecular beacon, and fluorescence
intensity at 523 nm was quantified. Fluorescence intensity for the linear DNA was
normalized to 100% (Figure 3-13). For comparison, the fully complementary linear bisazido DNA as well as a DNA scramble sequence were also monitored. Circularization
and caging of the Ru-cDNA was confirmed by a 2.3-fold lower fluorescence intensity
when compared to the linear complementary DNA (Table 3-3), under thermal annealing
conditions that greatly favored hybridization. After visible light exposure, fluorescence
intensity was restored to match the intensity of the bis-azido complementary DNA. This
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confirms complete uncaging and hybridization restoration upon short exposure to blue
light.
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Figure 3-5. Change in UV-Vis spectrum of RuBEP upon 450-nm focal irradiation.
RuBEP in H2O was continuously irradiated with 450 nm (53 mW/cm2) and wavelength shift was
monitored. Two isosbestic points were detected. A yellow to orange color change was visible
upon ligand exchange (inset).
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Figure 3-6. Electrospray mass spectrometry of [RuBEP])PF6)2 +/- light
A) RuBEP PF6 salt before irradiation, showing a doubly charged species at 310.06 Da. Expected
mass = 620.13 Da (z=1), 310.06 Da (z=2) B) RuBEP + 450 nm (5 min, 14 mW/cm2) showing
singly charged species at 552.05 Da, confirming the exchange of one 3EP ligand upon irradiation.
Expected mass = 552.02 Da (z=1)
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Figure 3-7. 1H NMR, pre- and post-photolysis of RuBEP in D2O.
A) Pre-photolysis 1H NMR. B) Post-photolysis 1H NMR (+450 nm, 5 min, 14 mW/cm2)
showing the appearance of a free 3-EP peak, and change in integration for bound 3-EP peak. The
appearance of a second alkyne peak confirms one ligand exchange with solvent (D2O).
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A

B
Moles Product Ru(bpy)23EP(OH2) = initial moles RuBEP – current moles RuBEP
current moles RuBEP
photons absorbed

Abs-εp [RuBEP]i
εs -εp

cuvet

E

(1)
(2)
(3)

Pl

Where:
P = net power of the laser during the trial (mW)
l

E = energy of 450 nm light (J/photon)
s = extinction coefficient of RuBEP (starting material) at 475 nm = 1800 M -1cm-1
p = extinction coefficient of Rubpy2(3EP)(H2O) (product) at 475 nm = 3800 M-1cm-1

Figure 3-8. Quantuim yield determination of RuBEP.
A) Kinetics trace of ligand dissociation of 14 μM RuBEP (0.2 OD) upon exposure 450 nm laser
(53 mW/cm2) under ambient conditions. Abs473 was monitored to determine formation of product,
Ru(bpy)2(3-EP)(H2O)Cl2 . B) Equations for quantum yield of photorelease calculation. Quantum
yield was determined to be 0.33 ± 0.06.
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1 – N -DNA-N
3

2 – 15 min rxn
3 – 30 min rxn

3

4

5

6

4 – N3-DNA-N3

7

6 – N3-DNA-N3

5 – 1 h rxn

7 – 2 h rxn

8

9

8 – N3-DNA-N3
9 – 3 h rxn

Figure 3-9. Time-course gel of DNA circularization
25 pmol aliquots were removed over the course of the DNA circularization reaction. Each aliquot
was run on a 15% PAGE/ 7M urea gel at 300 V for 45 min and stained for 15 min with EtBr.
Click reaction aliquots were compared to the linear bis-azido DNA migration (lanes 1, 4, 6, 8).
Circular product appeared as the fastest migrating band, within the first 15 min of the reaction,
with more product formation at 3 h (lane 9).
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Figure 3-10. Mono-azide DNA click reaction
Lane 1 – N -DNA only, Lane 2 – N -DNA clicked, Lane 3 – N -DNA clicked + 450 nm light.
3

3

3

A mono-azido DNA 25mer was subjected to the same conditions given above for the bis-azide
DNA. The circularization efficiency was monitored on a 15% PAGE/7 M urea gel, run for 45 min
at 300 V. The gel was stained for 15 min with EtBr. A band (lane 3) running slower than the N 3DNA appeared, and intensity was decreased after photolysis. Only 50% decrease in photoloysis
was seen, as only one 3EP ligand on RuBEP will exchange upon light exposure. The higher band
in lane 2 is likely dimer, DNA-RuBEP-DNA.
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1

2

Figure 3-11. 20%, 7 M urea PAGE analysis of Ru-cDNA after HPLC purification
HPLC isolation of Ru-cDNA from Figure 3-4B. Lane 1. N -DNA-N (TR = 27.5), Lane 2. RucDNA after HPLC purification (TR = 22.5 min)
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Figure 3-12. Calibration curve for molecular beacon targeting ntl
To confirm opening of MB in presence of fully complementary MO, linear ntl-MO was
hybridized to MB in ratios ranging from 0.1:1 to 5:1 and fluorescence intensity was measured at
523 nmafter thermal annealing.
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Figure 3-13. Molecular beacon hybridization assay for Ru-cDNA
Molecular beacon fluorescence assay showing less probe hybridization to caged Ru-cDNA
compared to the linear DNA or Ru-cDNA after 3-min exposure to 450-nm light. Samples were
annealed prior to molecular beacon assay to promote hybridization.

Table 3-3. Relative fluorescence intensities for molecular beacon targeting ntl-DNA

background

Relative fl. intensity at
523 nm
0

mismatch

21.3%

circular caged
56.5%
complementary
99.6%
N3-DNA-N3
circular uncaged 100%
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C. Ru-cMO
In order to photoregulate gene expression in living zebrafish embryos, two early
developmental zebrafish genes were targeted, notail (ntl) and chordin (chd), due to their
well characterized and easily recognizable knockdown phenotypes with antisense MOs.37
Examples of these knockdown phenotypes are shown in Figures 3-14 and 3-15. Upon
knocking down chd with an antisense MO, zebrafish embryos will develop with a
decreased head size, U-shaped somites, and a large "blood island" on the tail (Figure 314). Knocking down ntl with an antisense morpholino results in zebrafish embryos with a
decreased head size, U-shaped somites, no notochord, and no posterior structures. These
phenotypes can range from mild to severe depending on the morpholino dose. Control
morpholino doses for both chd and ntl were titrated by injecting varying concentrations
of morpholino to achieve the strongest phenotype while limiting toxicity and off-target
effects. These optimal concentrations were found to be 0.5 mM and 0.25 mM for chd and
ntl, respectively.
The RuBEP-DNA circularization conditions were subsequently applied to
antisense MOs (Scheme 3-1). Bis-azido MOs were purchased from Gene Tools
(Philomath, OR) and added to RuBEP in a 1.05:1 ratio in the presence of 10x Cu(I)Br
and 20x chelator, TBTA (Table 3-1). These reaction conditions promoted reaction of one
RuBEP per MO, thus favoring intramolecular reaction and circularization. Reaction
conditions varied slightly depending on sequence, as solubility of morpholinos is related
to the number of guanine residues in the sequence. For chd, 10.5 nmol MO was added to
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10 nmol RuBEP in 25 µL. The reaction volume for ntl was increased to 100 µL to
increase solubility (due to higher guanine content). The reaction proceeded for 24-48 h at
rt. Although product was formed within the first 15 minutes of the reaction, product was
maximized after 24-48 h (Figure 3-18).
Due to the neutral charge of morpholinos, the click product, Ru-cMO could not be
analyzed using standard PAGE or HPLC as Ru-cDNA was. Instead, formation of RucMO was monitored by gel-shift assay employing a 25mer complementary DNA strand.
The control MO or Ru-cMO was hybridized to a complementary DNA to provide charge
density for gel migration. This MO:DNA hybrid was run on a 15% native polyacrylamide
gel on ice (100 V, 120 min) and stained with ethidium bromide, shown in Figure 3-16. As
expected, the complementary DNA (lane 1) ran slower when hybridized to linear bisazido MO (lane 2). Upon circularization (lane 3), the Ru-cMO:DNA hybrid migrated
even slower, which can be attributed to its weaker duplex stability. An additional band
(band 4) is seen in lane 3 likely due to the less stable duplex causing dehybridization of
some DNA during the gel-shift assay. Photoactivation at 450 nm (14 mW/cm2, 3 min)
resulted in complete uncaging, yielding a mono-Ru-functionalized linear MO that was
hybridized to DNA (lane 4) and ran comparably to the MO:DNA hybrid (lane 2). All
lanes contained stoichiometric complementary DNA (lowest band) to promote
hybridization. For Ru-cMO-chd, QuantIT band quantification showed less than 5%
unreacted bis-azido MO after 48-h RuBEP reaction (Figure 3-16). Typical reaction yields
ranged from 87–95% circularization, determined by band size and intensity
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quantification. No additional purification of Ru-cMO was necessary due to high
circularization efficiency. Reaction efficiency for Ru-cMO-ntl was slightly lower and
contained a linear Ru-MO side reaction, due to mono-azido MO impurity in the bis-azido
MO obtained from Gene Tools (Figure 3-17).
A molecular beacon was designed targeting chd-MO, with a fluorophore (5'FAM) and quencher (3'-BHQ1), and 6-nt complementary stem (Table 3-7). The
molecular beacon fluorescence assay was performed to confirm caging of the Ru-cMOchd construct. Fluorescence signal from the molecular beacon was very strong when
hybridized to linear MO (Figure 3-19), setting the baseline for this measurement. By
comparison, fluorescence intensity was 2.6-fold lower with Ru-cMO-chd, indicative of
caging. After exposure to 450 nm light (14 mW/cm2, 3 min) the fluorescence intensity
was restored within error of the linear MO, confirming complete uncaging. These data
agreed well with the gel-shift assay (Figure 3-16) which also showed that some
hybridization occurred, although to a lesser extent than the linear control. This can be
attributed to forced hybridization through heating and cooling in both the gel and the
molecular beacon assay.
The circular construct, Ru-cMO-chd, was tested in vivo in living zebrafish
embryos to assess the ability to photoregulate gene expression with RuBEP caged
morpholinos. Ru-cMO-chd (514 pmol/µL) was microinjected into zebrafish embryos at
the one-cell stage. Half of the injected embryos were incubated at 28 °C in the dark,
while the other half were irradiated with 450 nm light (14 mW/cm2, 5 min). Another
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batch of embryos were injected with control linear bis-azido MO targeting chd at the
same concentration. At 24 hpf, the embryos were scored for phenotypic response (Table
3-4) and imaged.38 Figure 3-20(A-D, E) shows representative images of the phenotypic
response and embryo phenotype scoring at 24 hpf. Figure 3-20A shows the uninjected
control emrbyos, where 100% developed as expected for wildtype TLF x TLF zebrafish.
In contrast, Figure 3-20D shows embryos injected with the control linear MO. These
embryos developed with varying degrees of chd knockdown phenotype, with 95%
showing a severe or moderate phenotype. A small percentage of these embryos (5%)
developed normally, which can be attributed to injection error. Embryos injected with
Ru-cMO-chd followed similar phenotypic trends as the controls. For the embryos
incubated in the dark, >86% developed normally, comparable to the uninjected control.
Embryos exposed to blue light developed similarly to the linear MO-chd control
injection. Over 92% of the embryos developed with the chd knockdown phenotype, with
greater than half of the embryos displaying a severe phenotype as was seen with the
linear MO-chd control. This confirms that the retained Ru moiety on the uncaged MO
does not affect MO activity in vivo. This is consistent with the molecular beacon assay,
where Ru-cMO after uncaging behaved identical to linear bis-azido MO. The 8% of
embryos with normal development can be attributed to injection variability.
To confirm sequence-specificity, identical experiments were performed with a
second gene, ntl39 (Figure 3-21). Similar caging results were obtained with Ru-cMO-ntl,
however, background MO activity was slightly higher. Of the embryos incubated in the
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dark, 4% developed with class IV phenotype (severe), however, a significant percentage
(26%) developed with a class II phenotype. This background activity can be attributed to
the linear Ru-MO due to the mono-azide impurity in the starting material from Gene
Tools (Figure 3-17). The embryos irradiated with blue light developed with varying
degrees of the ntl phenotype.
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Figure 3-14. chd-MO knockdown phenotype
The no-chordin phenotype ranged from severe to mild where severe was identified by a
significantly decreased head size, U-shaped somites, and a large blood island on the tail.
Moderate and mild phenotypes were both identified by U-shaped somites and blood island, to
varying degrees.
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Figure 3-15. ntl-MO knockdown phenotype
Zebrafish embryos were injected at the 1-cell stage with 0.25 mM ntl-MO and imaged at 24 hpf.
The notail morpholino knockdown phenotype ranged from severe (class 4) to mild (class 2)
where severe is identified by a significantly decreased head size, U-shaped somites, no notochord,
and no posterior structures. Class 3 is identified by U-shaped somites, no notochord, and
significantly shortened posterior structures. Class 2 is identified by U-shaped somites, a shortened
posterior axis, with the notochord still present.
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Figure 3-16. Gel-shift assay showing Ru-cMO formation and photolysis
15% native PAGE gel-shift assay showing formation of Ru-cMO-chd (lane 3), and subsequent
photolysis with 450 nm light (14 mW/cm2, 3 min) (lane 4). Complementary DNA and DNA/MO
hybrid controls are show in lanes 1 and 2, respectively. Lane numbers are shown in black and
band numbers are shown in red.
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Figure 3-17. ntl-MO circularization
15% native PAGE gel-shift assay showing controls (lanes 1 and 2) and formation of Ru-cMO-ntl
(lane 3). Circular product is indicated by the arrow. No additional purification was performed
before in vivo testing. Due to initial impurities of bis-azido-ntl MO, the same circularization
efficiency could not be achieved as with bis-azido-chd MO. Lane 1. complementary DNA, Lane
2. DNA: ntl MO hybrid, Lane 3. Click reaction 1.05:1 (MO: RuBEP), RT, 24 h. Lane numbers
are shown in black and band numbers are shown in red. Band 4 represents complementary DNA,
band 3 represents a singly clicked impurity as a result of initial N3-MO impurity, band 2
represents Ru-cMO product, and band 1 represents dimerized product.
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Figure 3-18. Time course gel-shift for Ru-cMO-ntl
15% native PAGE gel-shift assay showing controls (lanes 1 and 2) and formation of Ru-cMO-ntl
(lanes 3-8). Circular product formation was monitored over a range of 15 min to 24 h. Lane 1:
complementary DNA, lane 2: DNA/ntl MO hybrid, lane 3: 15 min rxn, lane 4: 30 min rxn, lane 5:
1 h rxn, lane 6: 6 h rxn, lane 7: 16 h rxn, lane 8: 24 h rxn. Band assignments are outlined in
Figure 3-17.
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Figure 3-19. Molecular beacon assay showing Ru-cMO-chd caging
Molecular beacon fluorescence assay showing less probe hybridization to caged Ru-cMO
compared to the linear MO or Ru-cMO after 3-min exposure to 450-nm light. Samples were
annealed prior to molecular beacon assay to promote hybridization.
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Figure 3-20. in vivo testing of Ru-cMO-chd
Representative images of 24-28 hpf zebrafish embryos, showing different degrees of chd
knockdown phenotype: A) Wildtype control embryo, uninjected. B) Ru-cMO-chd, incubated in
the dark, showing normal development. C) Ru-cMO-chd, irradiated for 5 min at 1 hpf with 450nm light, showing no-chordin phenotype. D) Bis-azido morpholino control showing no-chordin
phenotype. All embryos were injected at 1-cell stage. E) Percent of embryos showing each of
four phenotypic responses.
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Figure 3-21. Ru-cMO-ntl in vivo data
Zebrafish embryos were injected with MO control at the 1-cell stage with 0.25 mM ntl-MO and
imaged at 24 hpf. For Ru-cMO, zebrafish embryos were injected at the 1-cell stage with 0.25 mM
Ru-cMO-ntl. Half of the embyros were irradiated (450 nm, 14 mW/cm2, 5 min) at 1 hpf, while
the other half were incubated in the dark. Embryos were scored for phenotype at 24 hpf.
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Table 3-4. Phenotypic scoring for Ru-cMO-chd in vivo

n value
Normal
Mild
Moderate
Severe

Wildtype

Ru-cMO -h

Ru-cMO +h

MO control

>100
100.0%
0.0%
0.0%
0.0%

94
86.2%
4.3%
5.3%
4.3%

66
7.6%
10.6%
31.8%
50.0%

78
5.3%
0.0%
46.7%
48.0%

Table 3-5. Phenotypic scoring for Ru-cMO-ntl in vivo

n value
Class I
Class II
Class III
Class IV

Wildtype

Ru-cMO -h

Ru-cMO +h

MO control

>100
100.0%
0.0%
0.0%
0.0%

26
69.2%
26.9%
0.0%
3.8%

23
17.4%
21.7%
43.5%
17.4%

44
2.3%
2.3%
45.5%
50.0%

Table 3-6. Ru-cMO MALDI data.
Samples were analyzed using 3-hydroxypicolinic acid (3-HPA) matrix in linear positive ion mode
on a Bruker Ultraflex III MALDI TOF/TOF mass spectrometer.

Ru-cMO-chd
Ru-cMO-ntl

Expected mass (Da)
9561
9357
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MALDI mass (Da)
9567
9385

Table 3-7. Oligonucleotide sequences, 5′ to 3′

DNA
Reverse
complement

GACTTGAGGCAGGCATATTTCCGAT
ATCGGAAATATGCCTGCCTCAAGTC

Molecular

6FAM-CCACCCATCGGAAATATGCCTGCCTCAAGTCGGGTGG-

beacon

BHQ1

chd-MO

ATCCACAGCAGCCCCTCCATCATCC

chd reverse
complement

GGATGATGGAGGGGCTGCTGTGGAT

chd molecular

6FAM-

beacon

CGGGCGGGATGATGGAGGGGCTGCTGTGGATCGCCCG-BHQ1

ntl-MO*

AGCTTGAGATAAGTCCGACGATCCT

ntl reverse
complement
DNA scramble

AGGATCGTCGGACTTATCTCAAGCT
AAAAAAAAAAAAAAAAAAAAAAAAA
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IV. Conclusion
The first example of a ruthenium photolinker, RuBEP, was synthesized and
characterized. RuBEP can be synthesized in high yields with a two-step synthesis.
RuBEP undergoes ligand dissociation with a high quantum yield upon exposure to 450
nm light. This ligand exchange is very clean and efficient, making RuBEP an optimal
photolinker for use in biological systems, and thus, RuBEP was used to cage DNA and
MO oligonuclotides. The alkyne groups on the 3-ethynylpyridine ligands reacted with
bis-azide-functionalized oligonucleotides to form cyclized, caged oligos in good yields
and purity. These Ru-circularized oligos underwent efficient Ru2+-ligand exchange upon
450-nm irradiation, to reveal the linear oligonucleotides. Ru-cMOs were tested in vivo
and efficient caging of antisense activity was achieved when the oligo was circularized.
Biological activity was restored upon 450 nm irradiation revealing the expected antisense
knockdown phenotypes in zebrafish embryos. Complete restoration of biological activity
confirmed that the pendant Ru2+ moiety did not adversely affect target hybridization or
biological activity (Figure 3-20E). In addition to the broad in vivo applications for Rumorpholinos, it is expected that RuBEP can be used to cage many other azidefunctionalized biomolecules, e.g., peptides, lipids, oligosaccharides. Finally, the versatile
1-P and 2-P inorganic photochemistry of [Ru(bipyridine)2(X)2]2+ complexes motivates
further development of Ru photolinkers to allow multiplexed caging/uncaging for diverse
applications.
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I. Introduction
The caging and precise spatiotemporal release of bio-active compounds is
becoming increasingly important in the field of nanomedicine. A particular focus has
been the development of chemical cages for metal ions, such as Zn2+ and Ca2+. Zinc is
required for normal cell function and important for both intracellular and extracellular
signaling. Lack of zinc homeostasis can retard growth and lead to immunodeficiency.1-3
The biological importance of Ca2+ has been studied extensively in muscle contraction,
cell signaling, gene regulation, thrombosis, wound healing, and cell death.4 Deficiencies
in zinc and calcium are common in the human population, and can lead to many
neurological, cardiovascular, and endocrine disorders.4,5 Strategies for further probing the
biological functions of these metal ions involve metal ion delivery to localized sites,
which has the advantage of avoiding homeostatic disruption in non-target areas.
Traditional approaches for caging metal ions have employed inorganic
coordination chemistry, where one or more multivalent ligands coordinates the metal ion,
and the release of the caged ion is achieved by modulating the dissociation constant, KD,
for the ligand-metal ion complex. A family of ligands has been developed for Zn2+ and
Ca2+ with weak and strong affinities.4,6-8 A common challenge with small-molecule
ligands is the lack of specificity where similar ions can compete for binding to the active
site.8 An extension of the thermodynamically-driven release of metal ions is
incorporation of stimulus responsiveness. Light has been used in conjunction with
coordination chemistry to provide a binary system that switches from caged to uncaged
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for both Zn2+ and Ca2+. In these systems, photoactive moieties such as o-nitrobenzyl,
fluoroionophores, and nitrodibenzofurans, were used for Zn2+ and Ca2+ caging.9-13 These
systems, however, require high doses of near-UV light for uncaging, which limits
biological compatibility and depth penetration in biological systems. Light penetration
into tissue can be improved with longer wavelengths or 2-photon excitation. However,
there are limited examples of caging metal ions with visible or NIR light. One example
by Canto et al. used spiropyran receptors conjugated to single-wall nanotubes (SWNTs)
for the reversible trapping and release of Zn2+ with visible light.14
Encapsulation within stimulus-responsive nanocarriers is a more generalizable
approach to metal ion caging/release compared to molecularly caged systems. The release
no longer depends on the ligand chemistry, enabling the same nanocarrier to be used for a
variety of different metal ion systems, or even to deliver multiple metal ions
simultaneously. Another advantage of nanocarriers over molecular cages is that the
number of metal ions that can be caged is not limited by the valency of the chelator. One
versatile class of nanocarriers is polymersomes, which are self-assembled bilayer vesicles
synthesized from amphiphilic diblock copolymers.15,16 They provide a large internal
aqueous environment for hydrophilic encapsulation and a hyperthick membrane for
hydrophobic encapsulation, and can be surface modified to provide targeting
capabilities.17-22
The work presented here specifically utilizes photoresponsive nanoscale
polymersomes for the encapsulation and delivery of metal ions with a visible light
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trigger. Previous examples of photoresponsive nano-polymersomes were limited to
incorporation of UV-active moieties within the diblock copolymer. Cabane et al.
presented a UV-responsive nano-polymersome containing an o-nitrobenzyl moiety
between the hydrophobic and hydrophilic polymer blocks, used to encapsulate and
release small molecular weight dyes and proteins.23 There are examples of other types of
nanocarriers that can be made photoresponsive such as micelles with embedded 2 photon
active photoswitches, reported by Zhang et al.24
Previous work done in our laboratory has shown that micron-scale polymersomes
synthesized from poly(ethylene oxide)-poly(butadiene) (OB29, MW = 3800 g/mol) can
be made photoresponsive through the addition of dextran in the aqueous core and mesoto-meso ethyne-bridged (porphinato)zinc(II) dimer, PZn2, in the hydrophobic membrane.
These vesicles undergo membrane deformation upon irradiation with visible light, as the
incorporate PZn2 is an effective chromophore in the visible to near-IR region.17,25,26 Here,
we present the extension of this work from micron-scale vesicles to vesicles that are 100
to 200 nanometers in diameter, a size regime amenable to the use of this system in
biological

applications.

Additionally,

we

demonstrate

the

ability

to

tune

photoresponsiveness of the system with visible light wavelength, irradiation time, and the
presence of dextran in the core. The system presented here shows efficient encapsulation
and release of a small molecule, fluorescein isothiocyanate (FITC), and two biologically
relevant metal ions, Zn2+ and Ca2+. This work is the first report of nano-polymersomes
for the encapsulation of metal ions and release with visible light.
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II. Experimental procedures

A. Self-assembly of micron-scale polymersomes
Micron-sized polymersomes were synthesized via a thin-film rehydration
method.26 Briefly, OB29 polymer solution (200 µL, 1 mM) in methylene chloride was
deposited onto the surface of a roughened Teflon square. The film was placed in a glass
vial and allowed to dry for 16-24 h to evaporate of the organic solvent. An aqueous
buffer (2 mL) containing the hydrophilic encapsulant in 290 mOsm sucrose was added to
the glass vial, submerging the polymer film entirely in the buffer. The glass vial was
capped and placed in a 60 °C oven for 12-16 h. After heating, the glass vial was rapidly
vortexed for 1 min to yield micron-sized polymersomes.

B. Self-assembly of nanoscale polymersomes
Nanoscale polymersomes were made by direct injection of aqueous buffer into a
solution of DMSO containing polyethylene oxide–polybutadiene (PEO30–PBD46, denoted
OB29, MW = 3800 g/mol). The final mixture contained 30% DMSO by volume. The
DMSO-buffer mixture was immediately vortexed for 5 min to promote vesicle selfassembly. Vesicle size and monodispersity were tuned through polymer concentration,
aqueous-to-organic volume ratio, and vortex time. To make light-responsive nanopolymersomes, a 10 mol% solution of PZn2 (2123 g/mol) was added to the DMSO
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solution prior to vortexing. Dextran (10 kDa) was added to the aqueous buffer to make a
10 mg/mL solution.

C. Encapsulation and purification
For micron-sized vesicles, hydrophilic encapsulants (fluorescently labeled
oligonucleotides, 5 nmol) were added to the sucrose hydration solution prior to the
vortexing. The polymersomes were purified to remove unencapsulated dextran and
fluorescently labeled oligonucleotide by centrifugation in a density step gradient. Before
centrifugation, the top layer contained the polymersome sample diluted in isosmotic PBS
and the bottom layer contained a solution of sucrose and density gradient medium (80%
sucrose/20% Optiprep by volume). The sample was spun at 10,000 RPM for 1 h at 4 ºC.
The polymersomes migrated to the PBS and sucrose/Optiprep interface and were
retrieved with a syringe. The polymersome sample was dialyzed against isosmotic PBS
(overnight, 4 ºC) to remove any remaining dextran, unencapsulated oligonucleotides, and
Optiprep in 50 kDa dialysis tubes (Thermo Scientific, Rockford, IL).
For nanoscale vesicles, hydrophilic encapsulants (dextran and oligo, FITC, or
metal ions) were added to the aqueous buffer prior to solvent injection and vortexing.
Fluorescein labeled morpholino (Fl-MO) loaded vesicles were synthesized by adding 5
nmol fl-MO to the 290 mOsm PBS hydration buffer. FITC-loaded vesicles were
synthesized with a saturated solution of FITC in 290 mOsm PBS. Ca2+-loaded vesicles
were synthesized with 150 mM CaCl2, and Zn2+-loaded vesicles were synthesized with
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150 mM ZnSO4. After vortexing, vesicles were dialyzed against the corresponding buffer
of equal osmolarity using a 50 kDa molecular weight cutoff dialysis cassette to remove
free 10 kDa dextran and unencapsulated hydrophilic cargo. Metal ion samples were
dialyzed against isosmotic NaCl for two days at 4 °C with at least two buffer changes. An
additional separation step was performed on samples that would be used for release
studies to ensure that all free encapsulant was removed. A 50 kDa molecular weight
cutoff Amicon Ultra centrifugal filter was used to separate any remaining free
hydrophilic encapsulant from the nanovesicles. The vesicles were spun at 10,000 rpm to
concentrate, and resuspended in buffer for further washes. This process was repeated
until free encapsulant could no longer be detected in the filtrate via UV/Vis absorbance.
A representative UV/Vis (Figure 4-1) shows the removal of unencapsulated
oligonucleotide with an Amicon centrifugal filter. The Abs260 measured in the flowthrough decreases with increasing number of spin/wash cycles.

D. Dynamic light scattering measurements
Polymersome size distribution was measured using a Malvern NanoZS Zetasizer.
Polymersome samples were diluted 10-fold in the corresponding aqueous buffer in 1 mL
polystyrene cuvettes. Size is reported as intensity %.
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E. Cryo-TEM measurements
Krishna P. Singh Center for Nantechnology: Lacey formvar/carbon grids (Ted
Pella) were cleaned with chloroform to remove the formvar coating, carbon coated with a
Quorum Q150 ES carbon coater (Quorum Technologies, UK), and cleaned with
hydrogen/oxygen plasma for 15 seconds using a Solarus Advanced Plasma System 950
(Gatan, Pleasanton, CA). The polymersome sample (2 µL) was deposited onto the grid
and inserted into a cryoplunger (Cp3, Gatan). The sample was blotted by hand with filter
paper and plunged into liquid ethane. The samples were subsequently transferred to a
Gatan CT3500TR cryoholder and inserted quickly into a JEOL 2100 HRTEM (JEOL,
Tokyo, Japan) operating at 200 kV. Images were captured using an Orius SC200 digital
camera.
Electron Microscopy Resource Laboratory: Lacy carbon grids were glow
discharged for 20 seconds at 25 mA to create a hydrophilic surface. A volume of 3
microliters of polymersome sample was applied and a thin film was formed by blotting
the grid with filter paper. Vitreous ice was formed by rapid plunging into liquid ethane
cooled to -180 °C by liquid nitrogen. Frozen hydrated samples were observed at -178 °C
in a FEI (Hillsboro, OR.) Tecnai-12 microscope operated at 80 keV at magnifications
indicated in the figure legends. Images were recorded on a Gatan (Warrendale, PA) US
1000 2048² CCD camera. All particle measurements were performed in Digital
Micrograph.
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F. Cargo release from polymersomes
Light-responsive polymersomes (30 µL) were irradiated in a PDMS well placed
on a 0.17-micron thick glass coverslip. An Olympus FV1000 confocal laser scanning
microscope equipped with multiple visible laser lines (488, 515, 543, 633 nm) was used
for irradiation. The sample was centered within the field of view of a 10x air objective
(Olympus UPlanSApo, NA = 0.40) lens, and subsequently irradiated for 1, 2, 5, or 10
min without sample evaporation occurring. Positive control release (100% release) was
achieved through the addition of a surfactant, Triton-X 100, to a final concentration of
0.1 vol%. Negative control samples (0% release) were kept at constant osmotic strength
and were not irradiated.

G. Detection of cargo release from nano-polymersomes
Fluorescent oligonucleotide (Fl-MO): After irradiation, 25 µL of sample was
removed from the PDMS well and placed into the filter of a 50 kDa molecular weight
cutoff Amicon Ultra 0.5 mL centrifugal filter. PBS (100 mM, 75 µL) was added to the
filter. The sample was centrifuged for 15 min at 10,000 rpm so that the released
oligonucleotide (6,000 - 10,000 Da) would flow through the filter but all vesicles (intact
or ruptured) and encapsulated oligonucleotide would remain in the filter. The flowthrough was collected and analyzed for fluorescence using a Cary Eclipse Fluorescence
spectrophotometer. The sample was placed in a small volume quartz cuvette (40 µL) and
excited at 494 nm. The emission spectrum was collected from 504 - 650 nm, and
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fluorescence intensity at 517 nm was used to calculate oligonucleotide release. Positive
and negative control vesicles were subjected to the same conditions.
Fluorescein isothiocyanate (FITC): After irradiation, 25 µL of sample was
removed from the PDMS well and placed into the filter of a 50 kDa molecular weight
cutoff Amicon Ultra 0.5 mL centrifugal filter. PBS (100 mM, 75 µL) was added to the
filter. The sample was centrifuged for 15 min at 10,000 rpm so that the released FITC dye
(MW = 389.4 g/mol) would flow through the filter but all vesicles (intact or ruptured) and
encapsulated dye would remain in the filter. The flow-through was collected and
analyzed for fluorescence using a Cary Eclipse Fluorescence spectrophotometer. The
sample was placed in a small volume quartz cuvette (40 µL) and excited at 494 nm. The
emission spectrum was collected from 504 - 650 nm, and fluorescence intensity at 517
nm was used to calculate FITC release. Positive and negative control vesicles were
subjected to the same conditions.
Ca2+: After irradiation, 6.25 µL of sample was removed from the PDMS well and
placed in a small volume quartz cuvette. A stock solution of Oregon Green 488 BAPTA1 hexapotassium salt in water was prepared to 1 µM. Oregon green stock solution (5 µL)
was added to the cuvette, and the Oregon Green/polymersome mixture was diluted 128fold. The sample was excited at 495 nm and the emission spectrum was collected from
505 to 650 nm. The fluorescence intensity at 523 nm was used to calculate Ca2+ release.
Positive control vesicles were achieved with the addition of Triton-X 100. Polymersome
sample (6.25 µL) was added to a small volume cuvette and Triton-X 100 was added to
144

achieve a final concentration of 0.1% v/v. This sample was then diluted 128-fold, and
analyzed for fluorescence intensity. Negative control vesicles were also diluted 128-fold
and analyzed for fluorescence intensity, without additional light or surfactant treatment.
Zn2+: After irradiation, 20 µL of sample was removed from the PDMS well,
placed into the filter of a 50 kDa molecular weight cutoff Amicon Ultra 0.5 mL
centrifugal filter, and diluted to 90 µL. The sample was centrifuged for 15 min and
10,000 rpm so that the released Zn2+ flowed through the filter but all vesicles (intact or
ruptured) and encapsulated metal ions remained in the filter. The flow-through was
collected and analyzed for fluorescence using a Cary Eclipse Fluorescence
spectrophotometer. The sample was placed in a small volume quartz cuvette (40 µL) and
5 µL of Oregon Green dye was added. The sample was excited at 495 nm and the
emission spectrum was collected from 505 to 650 nm, and fluorescence intensity at 523
nm was used to calculate Zn2+ release. For positive control vesicles, Triton-X 100 was
added to the sample before filtering, to a final concentration of 0.1% v/v. Negative
control vesicles were untreated, but also spun in centrifugal filters.

H. Microinjection into zebrafish embryos
Nano-polymersomes were concentrated in a 10 kDa molecular weight cutoff
Amicon centrifugal filter. Sample volume was concentrated 4-fold from the original
sample and used for injections with no additional preparation. Zebrafish embryos were
obtained from the CDB Zebrafish Core Facilty at the University of Pennsylvania
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Perelman School of Medicine. All embryos obtained were TLF x TLF (WT). All
injections were performed at the one-cell stage and injected into the cell compartment
only. A Harvard Apparatus PLI-100 pico-injector was used to inject controlled volumes.
Injection volume was calibrated to dispense 10 nL per embryo. Embryos were imaged
with an Olympus FV1000 laser scanning confocal microscope using transmitted light
imaging, as well as imaged for PZn2. A 10x air objective (Olympus UPlanSApo, NA =
0.40) was used for single embryo imaging and 4x air objective (Olympus UPlanSApo,
NA = 0.16) was used for multiple embryo imaging.

I. Porphyrin dimer (PZn2) wavelength shift determination
A CRi Multispectral Imaging System, NuanceFX camera attached to an Olympus
IX81 inverted microscope, was used for measurement of PZn2 emission spectrum before
and after irradiation. Epi-fluorescence illumination was used for PZn2 excitation with a
mercury-arc lamp and 530–550 nm band-pass filter. A three-dimensional image cube
measuring PZn2 emission from 660–720 nm in 3-nm steps was collected by the camera
through a 10x air objective (Olympus UPlanSApo, NA = 0.40). The PZn2 emission
spectrum was determined for select regions of interest using the Nuance 2.10 real
component analysis software.
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J. Materials
PEO30–PBD46 (OB29) was purchased from Polymer Source (Quebec, Canada).
Oregon Green 488 BAPTA-1 hexapotassium salt was purchased from Life Technologies
(Grand Island, NY). PBS (10x), DMSO (ACS reagent grade), CaCl2 (dihydrate), ZnSO4
(heptahydrate), and Slide-a-lyzer G2 dialysis cassettes, were purchased from Fisher
Scientific (Pittsburgh, PA). Amicon Ultra centrifugal filters were purchased from
Millipore (Billerica, MA).
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Figure 4-1. Abs260 measurement of Amicon flow-through for vesicle purification
Nanovesicles containing oligonucleotide were separated from free-oligonucleotide with an
Amicon centrifugal filter. The flow-through for each spin/wash cycle was measured for Abs260
until free oligonucleotide was no longer detectable.
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III. Results and discussion

A. Thin film self-assembly vs. Direct injection
A standard method of vesicle self assembly to maximize vesicle yield and
monodispersity was developed. To yield micron-sized vesicles, 1 mM of polymer was
cast onto a thin teflon film, incubated with the aqueous hydration solution, and vortexed
to promote self-assembly.26 To yield nano-vesicles through this same method, selfassembly is initiated through sonicating instead of vortexing. Although this method
generated fairly monodisperse vesicles, the yield of vesicles was limited due to the
amount of polymer that could be dried on the Teflon film. The concentration of polymer
for the system was limited to 1 mM to achieve a smooth film.
To allow for higher concentrations of polymer to maximize nano-polymersome
yield, a different method of self-assembly was investigated where a solution of polymer
in DMSO was directly mixed into buffer. This direct injection method has many benefits
over the thin-film method of self assembly. Primarily, this method allows for the
incorporation of higher polymer concentrations, limited only by the solubility of the
polymer in DMSO. By increasing the polymer concentration, the nanovesicle yield was
significantly increased. Additionally, the polymer drying and hydration solution
incubation steps were eliminated, shortening the vesicle preparation process. To achieve
the maximum yield of vesicles, while preserving vesicle shape, size, and monodispersity,
a variety of different self-assembly conditions were tested.
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B. Effect of mixing, aqueous-to-organic ratio, and polymer concentration on
self-assembly of nanoscale polymersomes
The effect of mixing was explored first for the direct injection self-assembly
method. For the initial screening, no hydrophobic encapsulants (PZn2) or hydrophilic
encapsulants (dextran, cargo) were included in vesicle preparation. The vesicles were
characterized dynamic light scattering (DLS), and cryo-TEM. Three methods of mixing
were tested for their effect on vesicle size and monodispersity: stirring, sonicating, and
vortexing. The first conditions tested were sonicating vs. stirring during the direct
injection process. For stirred samples, a micro stir bar was placed into a 2 mL glass vial
and placed on a magnetic stir plate. The organic (OB29 in DMSO) solution was injected
into the aqueous solution (0.1 M PBS) while stirring. For sonicated samples, the organic
solution was injected into the aqueous solution in a 2 mL glass vial while sonicating.
Both samples were infused at a rate of 10 µL/min. The samples were dialyzed to remove
the DMSO and both samples were characterized by DLS and cryo-TEM. A comparison
of the two samples is shown in Figure 4-2. Stirring resulted in uniform particles,
however, the average size of 60 nm is too small for the encapsulation of biomolecules,
and not ideal for in vivo applications. Although DLS was promising for the sonicated
sample, showing an average size of 150 nm, cryo-TEM showed a significant amount of
complex, non-vesicular structures. The aqueous infusion rate was varied between slow
infusion (10 µL/min) and direct injection, and no difference was observed on DLS or
cryo-TEM. Direct injection was used for subsequent samples.
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Vortexing was also explored as a method promoting self-assembly. Four different
vortex durations (1, 5, 10, and 20 min) were tested for two different concentrations of
polymer. A 1 mM solution of OB29 in DMSO was directly injected into PBS in a glass
vial. The vial was immediately capped and each sample was continuously vortexed. The
same series of samples were also made for 3 mM OB29 in DMSO. The samples were
dialyzed to remove DMSO and then analyzed by DLS. A clear trend was seen for both
polymer concentrations as shown in Figure 4-3. After 1 min of vortexing there were two
peaks, likely representing both micelles, and unassembled polymer. As vortex time
increased these peaks converged to one peak centered around 100 nm. There was no
significant change after 5 min, indicating that the self-assembly process was complete.
These samples were also analyzed by cryo-TEM (Figure 4-4) to determine the effect of
vortex time on morphology. Consistent with DLS, the 1 min vortex sample showed a
significant amount of micelle formation. The 5, 10, and 20 min vortexed samples showed
unilamellar, monodisperse vesicles, with very limited presence of non-vesicular
structures.
Another variable in the direct injection self-assembly process was the ratio of
organic-to-aqueous solvent. Previous samples were made with 30% v/v DMSO in buffer.
This percent was varied from 10, 30, 50, and 70% for four different polymer
concentrations in DMSO. The vesicles were dialyzed to remove DMSO and analyzed
with DLS and cryo-TEM. Figure 4-5 shows the negligible effect that the organic-toaqueous ratio had on vesicle size determined by DLS for 1, 1.5, 2, and 3 mM OB29
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concentrations. However, when these samples were visualized by cryo-TEM (Figure 4-6)
a very significant difference in morphology was seen. Although unilamellar vesicles were
present in all samples, 10% and 70% DMSO had a large amount of non-vesicular
structures, such as worms and micelles. The 30% and 50% DMSO samples both yielded a
large amount of uniform, unilamellar vesicles of the desired size. Because DMSO
removal is necessary for biological applications, 30% DMSO was a better choice for this
system.
The effect of concentration on vesicle size was also explored. Figure 4- shows a
slight difference in vesicle size between 1, 1.5, 2, and 3 mM OB29 in 30% DMSO.
Vesicles prepared with 1 mM and 3 mM OB29 resulted in slightly smaller vesicles.
Vesicles prepared with 1.5 mM and 2 mM OB29 resulted in vesicles of a more desirable
size, making these concentrations a reasonable choice for vesicle preparation.
Thorough self-assembly characterization resulted in the following optimized
vesicle preparation conditions: Direct-solvent injection of 30% DMSO containing 1.5 - 2
mM OB29 into 0.1M PBS, immediately capped and vortexed for 5 min, followed by
dialysis to remove DMSO. To make these vesicles light-responsive, 10 mol% PZn2 was
added to the polymer in DMSO solution. These vesicles were dialyzed and imaged with
cryo-TEM to confirm the desired morphology and size with the addition of a
hydrophobic encapsulant. Figure 4-8 shows vesicle size and morphology using the
optimized conditions.
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Figure 4-2. Effect of stirring vs. sonicating during nanovesicle self-assembly
A comparison of nanovesicles prepared with stirring vs. sonicating. Stirred samples resulted in
uniform vesicles < 100 nm in diameter. Sonicated samples resulted in larger vesicles and
asignificant amount of non-vesicular wormlike structures.
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Effect of
vortex time

Figure 4-3. Effect of vortex time on nano-vesicle size
DLS showing the effect of vortex time on vesicle size. Vesicles were prepared by directly
injecting OB29 in 30% DMSO into 0.1 M PBS followed by immediate vortexing. Vesicle size
converged by 5 min for both concentrations.
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Figure 4-4. Effect of vortex time on nano-vesicle morphology
Cryo-TEM images showing the effect of vortex time on vesicle morphology. Vesicles were
prepared by directly injecting OB29 in 30% DMSO into 0.1 M PBS followed by immediate
vortexing. A) 1-min vortexing resulted in a large number of micelles. B) 5-min vortexing
resulted in uniform, unilamellar vesicles. C, D) 10-min and 20-min vortexing showed no
significant change from 5 min.
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Figure 4-5. Effect of organic to aqueous ratio on nano-vesicle size
DLS measurements showing no significant effect on organic (OB29 in DMSO) to aqueous (0.1 M
PBS) ratio. Legend % represents percent DMSO in final solution.
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Figure 4-6. Effect of organic to aqueous ratio on vesicle morphology
Cryo-TEM images showing the effect of organic to aqueous ratio on vesicle morphology. A) 10%
final DMSO resulted in vesicles and worms. B, C) 30% and 50% final DMSO resulted in
uniform, unilamellar vesicles. D) 70% final DMSO resulted in vesicles and worms.
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Figure 4-7. Effect of polymer concentration on nanovesicle size
DLS measurements showing differences in vesicle size with varying OB29 in DMSO
concentration.
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Figure 4-8. DLS and cryo-TEM showing final conditions for nanovesicle self-assembly
Vesicles prepared with DMSO containing 1.5 mM OB29 and 10% w/w of PZn2, directly injected
into 0.1 M PBS followed by 5 min of vortexing. Vesicles were dialyzed to remove DMSO. A)
Size distribution of polymersomes in (B) as determined by dynamic light scattering. B) cryoTEM image of polymersomes containing 10% PZn2 in the membrane.
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C. Nanovesicle rupture determined by PZn2 emission shift
The meso-to-meso ethyne-bridged (porphinato)zinc(II) fluorophore (PZn2, Figure
4-9) has been previously reported to undergo an emission shift in response to its
environment; deformation of micron-scale OB29 vesicles was monitored by this
approach .27 Encapsulation within the nano-polymersome membrane restricts the mean
PZn-PZn torsional angle, causing PZn2 to adopt a more planar structure and red-shift in
emission compared to emission in solution. Upon irradiation and membrane
destabilization, PZn2 encounters more free volume within the membrane and can increase
its mean torsional angle, causing a blue-shift in emission relative to the unirradiated
state.27 Thus, PZn2 emission wavelength is a convenient and accurate way to monitor
membrane destabilization. We expect PZn2 to maintain a similar conformation within
nano-polymersomes as micron-polymersomes because the thickness of the hydrophobic
membrane does not change.28
To probe nanovesicle rupture, vesicles were irradiated with visible light for
increasing amounts of time (1, 5, 10, 20 min). A multispectral imaging camera was used
to determine an aggregate PZn2 emission of the bulk polyersome-containing solution
after each irradiation period. PZn2 emission blue-shifted from 714 nm to 705 nm with
increasing irradiation times (Figure 4-10A), consistent with PZn2 adopting a more twisted
structure in a less conformationally restricted environment (Figure 4-10B). The quantum
yield for release was not determined, however, 20-min irradiation correlated well with a
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positive control release sample where a surfactant, Triton-X 100, was added to fully
destabilize the membrane. These data were consistent with vesicle rupture.
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Figure 4-9. Structure of meso-to-meso ethyne-bridged (porphinato)zinc(II) dimer (PZn2)
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Figure 4-10. Membrane deformation detected by PZn2 emission blue-shift.
A) The emission spectra for PZn2 in nano-polymersomes were detected as function of irradiation
time. The emission blue-shifted with increasing irradiation time. B) Normalized ratio of I714
(planar) to I705 (twisted).
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D. Encapsulation and release of oligonucleotides
To confirm that oligonucleotides preferentially reside in the aqueous core, initial
loading experiments were explored in micron-sized vesicles and confocal laser scanning
microscopy (CSLM) was used for imaging. A 25-mer fluorescently labeled antisense
morpholino (fl-MO) was purchased from Gene Tools (Philomath, WA) and loaded in
micron vesicles according to methods described in section 4II-A and 4II-C. Micron-sized
vesicles were imaged, and distribution of fluorescence was seen throughout the aqueous
core as shown in Figure 4-11. A dual-loading experiment was performed to confirm
localization of PZn2 in the hydrophobic membrane and a 25-mer Alexa-488 labeled DNA
in the aqueous core (Figure 4-12). Finally, control vesicles containing no aqueous or
hydrophobic encapsulants were imaged to confirm fluorescent signal was due to PZn2
and fluorescently labeled oligos (Figure 4-13).
Nanovesicles containing fl-MO were prepared by including 5 nmol of fl-MO in
the aqueous solution (0.1 M PBS) prior to the self-assembly process. PZn2 (10 mol%) and
10k dextran (10 mg/mL) were included to make the vesicles light-activatable. To
quantify fl-MO loading in nanovesicles, unencapsulated fl-MO was separated and
quantified. After self-assembly, the vesicles were dialyzed against 0.1 M PBS in a 3.5
kDA molecular weight cutoff dialysis cassette to remove DMSO, but retain all fl-MO.
Unencapsulated fl-MO was then removed with a 50 kDa molecular weight cutoff Amicon
centrifugal filter. Quantification of fl-MO with Abs260 revealed a total fl-MO
encapsulation of 0.58 nmol, or 11.5% of the starting quantity. This quantity was
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corroborated with quantification by the fluorophore with a standard curve. Attempts were
made to increase fl-MO loading efficiency by increasing the starting quantity, however,
this resulted in similar absolute loading. This suggests that the maximum amount of
loading is governed by vesicle size and number, not by starting concentration.
Release experiments were done to determine the amount of fl-MO released as a
function of irradiation time. fl-MO-loaded nanovesicles were placed in a PDMS well and
irradiated with confocal lasers (488, 515, 543, 633 nm) for increasing amounts of time (0,
2, 10, 20 min). Positive (0.1% Triton-X 100) and negative (untreated) control samples
were also prepared. Fl-MO was removed by sizing with an Amicon centrifugal filter. The
released fl-MO was quantified by fluorescein emission (Figure 4-14). The percent release
was calculated by dividing the fluorescence of the irradiated sample by the fluorescence
of 100% release (Equation 1). A positive control was used as 100% release, and a
negative control was subtracted out as background. These values were corrected for
minor variations in volume. Percent release was plotted as a function of time, shown in
Figure 4-15.

Equation 1:

Within the first 2 min of irradiation, 9% of fl-MO was released. Release with time
was fairly linear, and after 20 min of irradiation this release increased to 61%. Although
this was a significant fractional release, the absolute quantity of fl-MO released after 20
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min of irradiation was approximately 350 pmol per 1 mL sample. To make this feasible
for in vivo antisense applications, this sample would have to be concentrated 1000-fold to
1 µL, risking particle aggregation. Thus, morpholino encapsulation and release with
nano-polymersomes was not pursued further.
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Figure 4-11. Encapsulation of fluorescein-labeled MO in micron vesicles
A) Fluorecein emission from fl-MO and B) DIC image. Scale bar represents 10 µm.
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Figure 4-12. Dual encapsulation of Alexa 488-DNA and PZn2 in micron vesicles
A) DIC image, B) Alexa-488 emission from DNA, and C) PZn2 emission. Scale bar represents 10
µm.
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Figure 4-13. Unloaded micron vesicles
A) PZn2 emission channel and B) DIC image. Scale bar represents 10 µm.
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Figure 4-14. Fluorescence intensity of fl-MO as a function of irradiation time
Nano-vesicles containing fl-MO were irradiated for increasing amounts of time. Released fl-MO
was separated out and quantified via emission at 517 nm. A positive control (0.1% Triton-X) and
negative control were also analyzed for fl-MO release.

169

70%
60%

% Release

50%
40%
30%
20%
10%
0%
0

5

10

15

20

25

Irradiation time (min)
Figure 4-15. Release curve for fl-MO loaded nanovesicles
Fractional fl-MO release was calculated as a function of irradiation time with 488, 515, 543, and
633 nm according to Equation 1. Release percentages were calculated comparing full (100%)
release with a surfactant (0.1% Triton-X).
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E. FITC loading and release from nanovesicles
To further probe this photoresponsive nano-polymersome system, a model
hydrophilic molecule, fluorescein isothiocyanate (FITC), was encapsulated. The
photoresponse of the nano-polymersomes was tuned by the irradiation time, presence of
dextran, and wavelength of light. Our previous work developed a generalized system for
tuning the photoresponsiveness of micron-sized polymersomes.26 It was determined that
including a high molecular weight dextran in the aqueous core of polymersomes and
PZn2 in the membrane was required for vesicle rupture. It was concluded that dextran
likely interacts with the inner leaflet of the bilayer membrane and reduces its elasticity,
whereas PZn2 (a highly absorptive chromophore with modest quantum yield) functions to
generate heat upon irradiation. The combined effect produces an asymmetric thermal
stretching of the membrane, ultimately causing rupture.26 We translated these findings to
photoresponsive nanovesicles, with a modification to encapsulate lower molecular weight
dextran (10 kDa) in the aqueous core due to the smaller luminal volume of nanopolymersomes. It was also hypothesized that the membrane could be destabilized from
the thermal expansion caused by PZn2 alone because of the increased curvature of
nanovesicles.
To assess the role for dextran, FITC was loaded into the aqueous core of nanopolymersomes with and without the inclusion of 10 kDa dextran in the aqueous core.
Both systems were irradiated with either 488-nm laser, or via combination of four visible
wavelength lasers (488, 515, 543, 633 nm). The combination of four lasers was chosen as
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an extension of our previous work with micron-vesicles, corresponding to several
absorbance features of PZn2 in the polymersome membrane. The 488-nm laser was
chosen as a single irradiation source as PZn2 absorbs maximally near this wavelength.
The release curves for these four conditions (+/- dextran, 488 nm/all lasers) are shown in
Figure 4-16. As expected, percent release (calculated from Equation 1) was identical
within experimental error when using 488 nm only (Figure 4-16B) vs. the combination of
visible lasers (Figure 4-16D). This provided additional evidence that vesicle rupture was
due to PZn2 absorption and not a non-specific effect of irradiation, as the combined laser
power was significantly greater than 488 nm alone. As hypothesized, due to the increased
curvature, nano-polymersomes ruptured without dextran (Figure 4-16A, 4-16C), contrary
to the previous micron-vesicle polymersome system. Nonetheless, dextran-loaded
nanovesicles consistently exhibited higher % release under all conditions tested (Figure
4-16). Nano-polymersomes were also prepared without PZn2 and dextran, and maximum
irradiation of these vesicles resulted in negligible FITC release (Figure 4-17), which
confirmed the need for PZn2.
These four conditions (+/- dextran, 488 nm or all lasers) provided a versatile
system that can be adapted to a variety of different experiments depending on factors
such as laser availability and desired amount of cargo release. To better understand the
mechanism of rupture, nano-polymersomes were imaged with cryo-TEM before and after
irradiation (Figure 4-18). Figure 4-18A shows a large population of uniform, unilamellar
vesicles before irradiation. After irradiation, a variety of non-vesicular structures were
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present (Figure 4-18B). These images suggest a rupture mechanism where the membrane
buckles and folds over itself, or is disrupted and reassembles. The mechanism is further
corroborated by DLS, showing no significant change in size post-irradiation. The cryoTEM images also provide insight as to why the release curves plateau without reaching
100% release. Figure 4-18B shows a large number of vesicles that reassembled after
membrane deformation. It is likely that the entire contents of the vesicle does not get
released prior to reassembly.

F. Loading and releasing metal ions with photoresponsive nanopolymersomes
To demonstrate the versatility of this system, encapsulation and release
techniques were applied to two metal ions with importance in cellular processes. Ca2+ or
Zn2+ was incorporated into the aqueous core of nano-polymersomes without any changes
to the direct-injection self-assembly process and the hydrodynamic diameter was
measured to confirm self-assembly (Figure 4-19). These vesicles were prepared both with
and without 10 kDa dextran and subjected to varying irradiation times with 488-nm laser.
Figure 4-20 shows release curves for Ca2+ (A) and Zn2+ (B). Both metal ions were
successfully loaded and released from nano-polymersomes, with maximum release
occurring for both ions after 10-min irradiation. Consistent with FITC photo-release, both
metal ions were released from nano-polymersomes not containing dextran in the aqueous
core, with a slightly lower fractional release. The concentration of Ca2+ after vesicle
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rupture was determined to be 757 µM from vesicles containing dextran, and 428 µM
from vesicles without dextran. The concentration of Zn2+ after vesicle rupture was 35 µM
with dextran and 11 µM without dextran. This was determined by full release from
vesicles with Triton-X 100 and quantified via corresponding Oregon Green-488
calibration curves. The average number of ions per vesicle was calculated to be 70,000,
assuming a polymer density of 1 chain/nm2, which has previously been used to calculate
vesicle number.29 Although the concentration of loaded Zn2+ is significantly lower
compared to Ca2+, it is appropriate for biological applications, as the cellular
concentration of free Zn2+ is typically on the picomolar to nanomolar range.30 Currently,
DM-nitrophen (Millipore, Billerica, MA) is the most efficient caged Ca2+ chelator, based
on its high calcium affinity before photolysis, and low affinity post-photolysis. Upon
irradiation with UV light (365 nm), DM Nitrophen can provide up to a 600 µM jump in
Ca2+ concentration in living neurons,4 however, DM Nitrophen must be employed at
similarly high concentration. As noted above, the nano-polymersome system can provide
a similar Ca2+ concentration jump, with the added benefits of visible-light release,
potential for greater biological stability, and the ability to encapsulate tens of thousands
of ions per vesicle. Further optimization of nano-polymersomes may be possible, for
example, to accelerate the rate and % yield of metal ion release.
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Figure 4-16. Release curve of FITC-loaded polymersomes
Nano-polymersomes containing PZn2 in the membrane were irradiated for various amounts of
time. A) Polymersomes containing no dextran in the core and irradiated with 488 nm laser. B)
Polymersomes containing 10 kDa dextran in the core and irradiated with 488 nm laser. C)
Polymersomes containing no dextran in the core and irradiated with 488, 515, 543, 633 nm lasers.
D) Polymersomes containing 10 kDa dextran in the core and irradiated with 488, 515, 543, 633
nm lasers.
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Figure 4-17. FITC release from nano-vesicles without PZn2 or dextran
Nano-polymersomes were made without PZn2 in the membrane or dextran in the aqueous core.
These vesicles were subjected to 20-min irradiation (488, 515, 543, 633 nm), and fluorescence
intensity was compared to a positive control sample (Triton-X added to 0.1 vol%). Release from
these vesicles was negligible.
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Figure 4-18. Morphological change in polymersomes after light irradiation.
Polymersomes containing 10% PZn2 in the membrane and 10 kDa dextran and FITC in the core
were imaged with cryo-TEM A) before light irradiation, and B) after 20-min irradiation with 488,
515, 543, 633 nm lasers.
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Figure 4-19: Hydrodynamic diameter of metal ion-loaded nanovesicles determined by DLS.
The hydrodynamic diameter of vesicles containing Ca2+ was determined to be 120 nm (blue) and
vesicles containing Zn2+ was determined to be 120 nm (red).
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Figure 4-20. Release curves of metal ion-loaded polymersomes.
Nano-polymersomes containing PZn2 in the membrane were irradiated for various amounts of
time. A) Ca2+-loaded polymersomes. B) Zn2+-loaded polymersomes.
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G. Nano-polymersomes in vivo
Initial screenings to determine in vivo applicability were explored. Nanovesicles
were prepared with PZn2 as a hydrophobic encapsulant and Texas-Red dextran in the
aqueous core. Vesicles were microinjected into zebrafish embryos at the 1-cell stage.
Immediately following injections, the embryos were imaged to determine vesicle
dispersion. The embryos were imaged up through 30 hpf. Figure 4-21 A-B shows the
embryos immediately after injection at the 1-cell stage. Both the PZn2 (A) and Texas Red
(B) channels show even distribution of the vesicles within the cellular compartment of
the embryo only. Figure 4-20 C-D shows the embryos at 20 hpf, with PZn2 (A) and Texas
Red (B) still detectable, and still evenly distributed through the embryo. The embryos
were monitored up through 30 hpf, and development and survival were comparable to the
uninjected controls. Embryos injected later than the 1-cell stage did not show even
distribution of vesicles throughout the cells, showing that the vesicles were not efficiently
distributed through cytoplasmic streaming, rather incorporated during cellular division.
To confirm passive uptake of nano-polymersomes in cells, uptake studies were
performed. Nano-vesicles prepared with PZn2 were added to cultured macrophages and
incubated for four hours. Cells were washed with PBS and imaged for PZn2 emission
within the cell (Figure 4-22). A z-stack image confirmed uptake within the cell and not
just adherence to the cell surface.
A PZn2 emission wavelength shift experiment was performed in zebrafish
embryos to probe vesicle rupture in vivo. Nanovesicles (4x concentrated) were
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microinjected into zebrafish embryos at the 1-cell stage. Confocal microscopy was used
to confirm nano-vesicle injection and cellular distribution at the 4-cell stage. A single
embryo was placed in a glass-bottom dish in E3 medium, and irradiated continuously
with 488 nm with an ROI selected to include only the cellular compartment (rastering the
ROI for 5 min). Embryos were imaged before (Figure 4-23A) and after (Figure 4-23B)
irradiation to confirm that PZn2 emission was still detectible, and to confirm that the
embryo was not damaged in the irradiation process. A NuanceFX multispectral camera
was used to measure the PZn2 emission wavelength from the cellular compartment only
before and after 5-min irradiation (Figure 4-23C). An identical wavelength shift was
observed in vivo as was seen in bulk, confirming vesicle rupture in zebrafish embryos.
The complete shift to 705 nm was seen with significantly less irradiation time in vivo
than in the bulk sample (5 min vs. 20 min), likely due to the smaller volume being
irradiated.
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Figure 4-21. Confocal images of zebrafish embryos injected with nanovesicles.
Zebrafish embryos were microinjected with nanovesicles containing PZn2 in the membrane
(purple) and Texas-Red dextran (red) in the aqueous core. Embryos were imaged at A,B) 1-cell
stage and C,D) 20 hpf to determine vesicle distribution and embryo viability. Single embryos
were imaged with a 10x objective and multi-embryo images were imaged with a 4x objective.
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Figure 4-22. Cell uptake of nano-polymersomes
Nanovesicles containing PZn2 were incubated with macrophages to confirm passive uptake. Cells
were imaged after 4 h incubation.
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Figure 4-23. PZn2 wavelength shift in vivo
A) PZn2 emission in a zebrafish embryo before irradiation and B) after 5 min irradiation with
488, 515, 543 and 633 nm. C) The emission spectra for PZn2 in nano-polymersomes were
detected as function of irradiation time. The emission blue-shifted with increasing irradiation
time.
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IV. Conclusion:
We reported a visible light-responsive nano-polymersome system capable of
encapsulating and releasing oligonucleotides, small molecules (FITC) and metal ions
(Ca2+ and Zn2+). This system uses PZn2, a hydrophobic porphyrin photosensitizer,
encapsulated in the membrane to provide thermal expansion and subsequent membrane
rupture. The inclusion of dextran in the aqueous core was probed for FITC and metal ion
systems, and shown to increase loading and fractional release. However, release can still
be

achieved

without

dextran,

unlike

our

previously

reported

micron-sized

photoresponsive polymersomes.26
Morpholino loading and release concentrations demonstrated were not sufficient
for in vivo knockdown experiments, however, this system could still be useful in
applications that require lower concentrations of oligo release. Importantly, we
demonstrated metal ion release at concentrations suitable for cellular applications. Our
system has many potential benefits over many previously reported caged chelators,
namely, the use of 488-nm light, and the ability to encapsulate different metal ions
without the need for modifying metal chelation or changing the self-assembly process.
The PZn2 emission shift provided a built-in reporter for vesicle rupture, which can be
useful for confirming spatiotemporal release in biological systems. Additionally, due to
the broad absorbance spectrum of PZn2, it is feasible to extend future work to releasing
with near-IR light, as PZn2 has λmax at 714 nm.17 Finally, it was demonstrated that
nanovesicles could be passively uptaken by cells, as well as microinjected into zebrafish
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embryos with no detectable toxicity. Vesicle rupture in vivo was demonstrated through a
PZn2 emission shift.
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Chapter 5

Conclusions and future directions
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I. Conclusions
The development of photoactivatable oligonucleotides has come a long way since
initial efforts in our lab where we demonstrated RNase H-dependent RNA digestion with
a light-activated DNA hairpin, and a light-responsive negatively charged peptide nucleic
acid hairpin for antisense activity in zebrafish embryos.1-4 Work presented in this thesis
expanded these photochemical tools to three new caging methods. A bidirectional photoregulated miRNA was designed to control a miRNA antagomir and exogenous miRNA
with 365 nm light.5 A ruthenium-caged morpholino for the photoregulation of antisense
activity was presented, extending the photoactivation wavelength to the visible spectrum.
Finally, a visible light-responsive nano-polymersome system was developed for the
encapsulation and release of a variety of cargo, including metal ions, oligonucleotides,
and a fluorescent dye.
Chapter 2 expanded upon our previously demonstrated caged hairpin design by
exploring the benefit of one vs. two nitrobenzyl moieties. Incorporating a second
photocleavable group within the blocking strand achieved a significantly higher Tm prior
to irradiation, and an overall larger ∆Tm between the photolyzed and caged construct.
This result was corroborated by remarkably low background activity (2%) prior to
irradiation due to the number of bases that could be rendered inactive through
hybridization with the biologically active miRNA antagomir. Additionally, this second
photocleavable group limited the amount of sequence specificity needed in the design, as
the near full-length blocking sequence needed little optimization in placement and length
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to block function. A circular miRNA presented in Chapter 2 was the first example of a
light-activatable miRNA for “turning on” an exogenous miRNA in vivo.
Chapter 3 presented the first example of a ruthenium photolinker, RuBEP, which
was activated with visible light. RuBEP was designed with two alkyne-containing ligands
for circularizing a bis-azido oligonucleotide through a Cu(I)-mediated [3+2] Huisgen
cycloaddition reaction. This Ru photolinker was applied to the circularization of two
morpholinos targeting early developmental genes in zebrafish, ntl and chd, and antisense
activity was successfully photomodulated with 450-nm light. Circular designs provided
benefits over hairpin designs, as the circularization process was nearly sequence
independent without the need for a blocking sequence. Additionally, the exclusion of a
blocking sequence avoided the risk of off-target effects upon dissociation.
Chapter 4 expanded caging techniques to the design of a light-responsive nanopolymersome. This design employed a meso-to-meso ethyne-bridged (porphinato)zinc(II)
dimer, PZn2, encapsulated in the hydrophobic membrane to harvest visible light for
membrane destabilization. Nano-polymersomes encapsulated a variety of cargo,
including oligonucleotides, a fluorescent dye, and metal ions. Photoresponsive release
was tunable with wavelength, irradiation time, and dextran inclusion in the aqueous core.
Nanocarriers provided a versatile method of caging through encapsulation, as a wide
variety of cargo can be contained in the aqueous core with no modulation to the selfassembly process.
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II. Future directions
New methods for caging oligonucleotides will soon make it possible to
incorporate a small library of caging designs and light-activatable moieties. Having
various caged oligos that can be photoactivated at different wavelengths will provide a
method of multiplexing, or controlling multiple oligos sequentially with high
spatiotemporal resolution.
One very promising application for multiplexing can be applied to recently
published work from our lab by Lovatt and Ruble et al., demonstrating a method for noninvasively harvesting mRNA from single cells using transcriptome in vivo analysis
(TIVA).6 This method used a hairpin design based on the design presented in Chapter 2
as well as published RNA bandage designs by Richards et al.,7 using a second
photocleavable moiety in the blocking strand to achieve a large ∆Tm between the pre- and
post-photolysis construct. The original TIVA design uses two nitrobenzyl moieties,
which optimally photolyzes with 365 nm light. To realize many potential applications, a
second TIVA-tag that photolyzes with visible light would be advantageous. Using
RuBEP as a photolinker to develop circular Ru-TIVA is currently being explored to
expand the TIVA-tag library, as well as to provide a TIVA construct that can be activated
with two-photon light (Yeldell et al., unpublished work). By using the first generation
TIVA-tag6 in tandem with Ru-TIVA, sequential pull-down of mRNA, or multiplexing,
may be achieved.
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More generally, a library of ruthenium-based photolinkers spanning the visible
spectrum will enable multiplexing for a multitude of applications, as RuBEP and future
Ru photolinkers have the potential to circularize any bis-azido oligonucleotide.
Additional applications potentially include elucidating gene regulatory systems in living
model systems, where sequential gene knockdown is necessary to probe function.
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Appendix A. Crystal structure determination of Ru(bpy)2(3-ethynylpyridine)2(PF6)2

I. Methods
Compound C34H26N6P2F12Ru•2½ acetone, crystallized in the Triclinic space
_
group P1 with a=11.2159(7)Å, b=12.5550(8)Å, c=18.1382(12)Å, =70.206(3)°,
=85.323(3)°, =67.450(2)°, V=2216.1(2)Å3, Z=2, and dcalc = 1.581 g/cm3. X-ray
intensity data were collected on a Bruker APEXII CCD area detector employing graphitemonochromated Mo-K radiation (=0.71073 Å) at a temperature of 100(1)K.
Preliminary indexing was performed from a series of thirty-six 0.5° rotation frames with
exposures of 10 seconds. A total of 2348 frames were collected with a crystal to detector
distance of 37.6 mm, rotation widths of 0.5° and exposures of 20 seconds:
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342.55

321.55
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243.20
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208



27.00
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5.00

57.63

221
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318.39

249.35

52.47

254



17.00

322.24

318.36

83.36

114



27.00

352.41

83.39

85.83

157



-18.00

124.02

292.98

-95.28

588

scan type

2
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Rotation frames were integrated using SAINT,3 producing a listing of unaveraged
F2 and (F2) values which were then passed to the SHELXTL4 program package for
further processing and structure solution. A total of 73021 reflections were measured
over the ranges 1.86  27.54°, -14  h  14, -16  k  16, -23  l  23 yielding 10200
unique reflections (Rint = 0.0189). The intensity data were corrected for Lorentz and

3

Bruker (2009) SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.

4

Bruker (2009) SHELXTL. Bruker AXS Inc., Madison, Wisconsin, USA.
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polarization effects and for absorption using SADABS 5 (minimum and maximum
transmission 0.6876, 0.7456).
The structure was solved by direct methods (SHELXS-976). Refinement was by
full-matrix least squares based on F2 using SHELXL-971. All reflections were used
during refinement. The weighting scheme used was w=1/[2(Fo2 )+ (0.0907P)2 +
0.3133P] where P = (Fo 2 + 2Fc2)/3. Non-hydrogen atoms were refined anisotropically
and hydrogen atoms were refined using a riding model. Refinement converged to
R1=0.0266 and wR2=0.0630 for 9570 observed reflections for which F > 4(F) and
R1=0.0292 and wR2=0.0655 and GOF =1.051 for all 10200 unique, non-zero reflections
and 643 variables.7 The maximum / in the final cycle of least squares was 0.002 and
the two most prominent peaks in the final difference Fourier were +1.120 and -0.826
e/Å3.
Table A1-1 lists cell information, data collection parameters, and refinement data.
Final positional and equivalent isotropic thermal parameters are given in Tables A1-2 and
A1-3. Anisotropic thermal parameters are in Table A1-4. Tables A1-5 and A1-6 list bond

5

Sheldrick, G.M. (2007) SADABS. University of Gottingen, Germany.

7

R1 = ||Fo| - |Fc|| /  |Fo|
2

2 2

2 2 ½

2

2 2

½

wR2 = [w(Fo - Fc ) /w(Fo ) ]
GOF = [w(Fo - Fc ) /(n - p)]

where n = the number of reflections and p = the number of parameters refined.
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distances and bond angles. Figure A1-1 is an ORTEP8 representation of the molecule
with 50% probability thermal ellipsoids displayed.

Figure A1-1. ORTEP drawing of RuBEP with 50% probability thermal ellipsoids.

8

“ORTEP-II: A Fortran Thermal Ellipsoid Plot Program for Crystal Structure Illustrations”. C.K.

Johnson (1976) ORNL-5138.
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Table A1-1. Summary of structure determination of [RuBEP](PF6)2
Empirical formula

C83H82F24N12O5P4Ru2

Formula weight

2109.63

Temperature

100(1) K

Wavelength

0.71073 Å

Crystal system

Triclinic
_
P1

Space group
Cell constants:
a

11.2159(7) Å

b

12.5550(8) Å

c

18.1382(12) Å



70.206(3)°



85.323(3)°



67.450(2)°

Volume

2216.1(2) Å3

Z

1

Density (calculated)
Absorption coefficient

1.581 Mg/m3
0.522 mm-1

F(000)

1068

Crystal size

0.42 x 0.26 x 0.10 mm3

Theta range for data collection

1.86 to 27.54°

Index ranges

-14  h  14, -16  k  16, -23  l  23

Reflections collected

73021

Independent reflections

10200 [R(int) = 0.0189]

Completeness to theta = 27.54°

99.6 %

Absorption correction

Semi-empirical from equivalents

Max. and min. transmission

0.7456 and 0.6876

Refinement method

Full-matrix least-squares on F2

Data / restraints / parameters
Goodness-of-fit on F2

10200 / 122 / 643

Final R indices [I>2sigma(I)]

R1 = 0.0266, wR2 = 0.0630

R indices (all data)

R1 = 0.0292, wR2 = 0.0655
1.120 and -0.826 e.Å-3

Largest diff. peak and hole

1.051
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Table A1-2. Refined positional parameters for [RuBEP](PF6)2
Atom

x

y

z

Ueq, Å2

Ru1

0.506258(11)

0.163868(11)

0.264396(7)

0.01291(4)

N1

0.65818(12)

0.13185(12)

0.19098(8)

0.0153(2)

N12

0.45450(12)

0.07306(12)

0.20479(8)

0.0149(2)

N13

0.57466(12)

-0.00632(12)

0.34959(8)

0.0155(2)

N24

0.35555(13)

0.17812(12)

0.33876(8)

0.0154(2)

N25

0.57819(13)

0.24338(12)

0.32652(8)

0.0155(2)

N33

0.41533(12)

0.33223(12)

0.17585(8)

0.0151(2)

C2

0.75831(15)

0.16753(15)

0.18526(10)

0.0188(3)

C3

0.85450(16)

0.14474(16)

0.13324(10)

0.0219(3)

C4

0.84615(17)

0.08520(16)

0.08327(10)

0.0235(3)

C5

0.74281(16)

0.04878(16)

0.08769(10)

0.0218(3)

C6

0.65119(15)

0.07173(14)

0.14269(9)

0.0169(3)

C7

0.54123(15)

0.03182(14)

0.15400(9)

0.0173(3)

C8

0.52811(17)

-0.04635(17)

0.11907(11)

0.0247(4)

C9

0.42495(18)

-0.08374(17)

0.13656(12)

0.0272(4)

C10

0.33660(17)

-0.04140(16)

0.18777(10)

0.0226(3)

C11

0.35404(15)

0.03707(15)

0.22011(9)

0.0180(3)

C14

0.68458(15)

-0.09937(15)

0.34717(10)

0.0195(3)

C15

0.71162(17)

-0.21890(16)

0.39519(11)

0.0247(4)

C16

0.62293(18)

-0.24480(16)

0.44906(11)

0.0261(4)

C17

0.51085(17)

-0.14999(16)

0.45341(10)

0.0222(3)

C18

0.48813(15)

-0.03161(14)

0.40305(9)

0.0165(3)

C19

0.36860(15)

0.07434(14)

0.40007(9)

0.0161(3)
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C20

0.27411(16)

0.07009(16)

0.45418(10)

0.0204(3)

C21

0.16281(17)

0.17312(17)

0.44612(10)

0.0235(3)

C22

0.15004(17)

0.27882(16)

0.38419(11)

0.0239(3)

C23

0.24783(16)

0.27815(15)

0.33221(10)

0.0198(3)

C26

0.50882(15)

0.35333(14)

0.33424(9)

0.0173(3)

C27

0.55503(16)

0.40441(15)

0.37742(10)

0.0200(3)

C28

0.67825(17)

0.33911(15)

0.41461(10)

0.0211(3)

C29

0.75013(16)

0.22637(15)

0.40647(10)

0.0198(3)

C30

0.69787(15)

0.18182(14)

0.36276(9)

0.0172(3)

C31

0.47574(18)

0.52329(17)

0.38143(11)

0.0262(4)

C32

0.4114(2)

0.62209(19)

0.38320(13)

0.0366(5)

C34

0.47048(15)

0.41520(14)

0.14776(9)

0.0164(3)

C35

0.41314(15)

0.52533(14)

0.08664(9)

0.0173(3)

C36

0.29400(16)

0.55052(15)

0.05305(9)

0.0191(3)

C37

0.23679(16)

0.46539(15)

0.08154(10)

0.0191(3)

C38

0.29993(15)

0.35806(15)

0.14190(9)

0.0174(3)

C39

0.47884(16)

0.60893(15)

0.05965(10)

0.0201(3)

C40

0.53479(18)

0.67633(17)

0.03667(11)

0.0259(4)

P1

0.91753(4)

0.07849(4)

0.63543(3)

0.01945(9)

F1

0.77189(10)

0.10137(11)

0.61329(8)

0.0342(3)

F2

1.06165(11)

0.05864(13)

0.65717(9)

0.0424(3)

F3

0.92791(14)

-0.04413(12)

0.70349(9)

0.0504(4)

F4

0.97134(12)

0.00549(13)

0.57550(8)

0.0439(3)

F5

0.90455(13)

0.20274(12)

0.56596(8)

0.0429(3)

F6

0.86228(11)

0.15488(12)

0.69372(7)

0.0368(3)
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P2

0.86742(4)

0.76441(4)

-0.00468(3)

0.02104(9)

F7

0.83036(18)

0.78269(12)

0.07795(8)

0.0564(4)

F8

0.89749(19)

0.75132(17)

-0.08864(9)

0.0644(5)

F9

0.71659(13)

0.81513(15)

-0.02793(10)

0.0695(6)

F10

0.86397(11)

0.90155(10)

-0.04003(7)

0.0306(2)

F11

1.01548(12)

0.71759(12)

0.01791(11)

0.0554(4)

F12

0.86992(12)

0.62856(11)

0.03176(8)

0.0373(3)

C41

0.8714(2)

0.33261(18)

0.77964(12)

0.0307(4)

C42

1.0085(2)

0.2875(3)

0.75661(19)

0.0539(7)

C43

0.8319(3)

0.2412(2)

0.84166(13)

0.0412(5)

O1

0.79828(19)

0.43755(14)

0.75071(11)

0.0501(4)

C44

0.7925(4)

0.4704(4)

0.2172(3)

0.0285(8)

C45

0.9341(4)

0.4331(4)

0.2064(3)

0.0467(10)

C46

0.7225(6)

0.5914(5)

0.2295(4)

0.0436(12)

O2

0.7350(3)

0.4074(3)

0.21545(17)

0.0437(6)

C47

0.7960(5)

0.5225(4)

0.2705(3)

0.0266(9)

C48

0.6794(7)

0.6370(7)

0.2342(5)

0.0403(16)

C49

0.8510(10)

0.4355(8)

0.2255(5)

0.052(2)

O3

0.8449(3)

0.5035(3)

0.33352(18)

0.0263(7)

C50

0.9372(4)

0.4879(4)

0.4842(3)

0.0275(9)

C51

0.8817(5)

0.4529(4)

0.5634(3)

0.0425(11)

C52

1.0506(5)

0.5301(5)

0.4789(3)

0.0392(11)

O4

0.8932(3)

0.4866(3)

0.42707(17)

0.0347(6)

Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos +2U13aa*cc*cos +2U23bb*cc*cos]
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Table A1-3. Positional parameters for hydrogens in [RuBEP](PF6)2
Atom

x

y

z

Uiso, Å2

H2

0.7632

0.2095

0.2178

0.025

H3

0.9235

0.1690

0.1319

0.029

H4

0.9089

0.0698

0.0473

0.031

H5

0.7349

0.0095

0.0542

0.029

H8

0.5881

-0.0732

0.0843

0.033

H9

0.4153

-0.1367

0.1141

0.036

H10

0.2665

-0.0653

0.2003

0.030

H11

0.2936

0.0662

0.2540

0.024

H14

0.7450

-0.0826

0.3117

0.026

H15

0.7882

-0.2811

0.3914

0.033

H16

0.6387

-0.3246

0.4816

0.035

H17

0.4508

-0.1651

0.4898

0.030

H20

0.2856

-0.0018

0.4957

0.027

H21

0.0982

0.1713

0.4815

0.031

H22

0.0766

0.3496

0.3775

0.032

H23

0.2386

0.3499

0.2911

0.026

H26

0.4265

0.3972

0.3097

0.023

H28

0.7113

0.3704

0.4441

0.028

H29

0.8329

0.1810

0.4302

0.026

H30

0.7473

0.1059

0.3580

0.023

H32

0.3608

0.6998

0.3846

0.049

H34

0.5502

0.3985

0.1700

0.022

H36

0.2535

0.6231

0.0122

0.025
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H37

0.1569

0.4803

0.0603

0.025

H38

0.2613

0.3009

0.1600

0.023

H40

0.5786

0.7291

0.0187

0.034

H42a

1.0273

0.3552

0.7214

0.081

H42b

1.0201

0.2290

0.7310

0.081

H42c

1.0658

0.2495

0.8027

0.081

H43a

0.8614

0.2331

0.8922

0.062

H43b

0.8695

0.1636

0.8335

0.062

H43c

0.7394

0.2679

0.8392

0.062

H45a

0.9675

0.3548

0.1992

0.070

H45b

0.9768

0.4278

0.2521

0.070

H45c

0.9493

0.4926

0.1612

0.070

H46a

0.6326

0.6048

0.2359

0.065

H46b

0.7310

0.6558

0.1848

0.065

H46c

0.7591

0.5910

0.2757

0.065

H48a

0.6533

0.6840

0.2689

0.060

H48b

0.6099

0.6152

0.2253

0.060

H48c

0.7006

0.6847

0.1851

0.060

H49a

0.9247

0.3670

0.2547

0.077

H49b

0.8769

0.4766

0.1757

0.077

H49c

0.7866

0.4072

0.2171

0.077

H51a

0.8093

0.4324

0.5583

0.064

H51b

0.8537

0.5205

0.5827

0.064

H51c

0.9467

0.3836

0.5994

0.064

H52a

1.0786

0.5469

0.4262

0.059
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H52b

1.1208

0.4668

0.5143

0.059

H52c

1.0229

0.6029

0.4928

0.059
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Table A1-4. Refined thermal parameters (U's) for [RuBEP](PF6)2
Atom

U11

U22

U33

U23

U13

U12

Ru1

0.01149(6)

0.01408(6)

0.01414(6)

-0.00525(4)

0.00267(4)

-0.00578(5)

N1

0.0133(6)

0.0157(6)

0.0157(6)

-0.0045(5)

0.0025(5)

-0.0053(5)

N12

0.0145(6)

0.0150(6)

0.0148(6)

-0.0042(5)

0.0016(5)

-0.0061(5)

N13

0.0141(6)

0.0169(6)

0.0169(6)

-0.0066(5)

0.0008(5)

-0.0066(5)

N24

0.0153(6)

0.0181(6)

0.0154(6)

-0.0072(5)

0.0027(5)

-0.0081(5)

N25

0.0160(6)

0.0164(6)

0.0146(6)

-0.0047(5)

0.0033(5)

-0.0075(5)

N33

0.0147(6)

0.0161(6)

0.0154(6)

-0.0066(5)

0.0031(5)

-0.0061(5)

C2

0.0170(7)

0.0220(8)

0.0192(7)

-0.0070(6)

0.0028(6)

-0.0095(6)

C3

0.0163(7)

0.0256(8)

0.0230(8)

-0.0052(7)

0.0047(6)

-0.0104(6)

C4

0.0195(8)

0.0262(8)

0.0232(8)

-0.0088(7)

0.0089(6)

-0.0080(7)

C5

0.0221(8)

0.0231(8)

0.0214(8)

-0.0104(7)

0.0061(6)

-0.0081(7)

C6

0.0153(7)

0.0157(7)

0.0182(7)

-0.0049(6)

0.0018(6)

-0.0052(6)

C7

0.0157(7)

0.0174(7)

0.0182(7)

-0.0063(6)

0.0017(6)

-0.0056(6)

C8

0.0229(8)

0.0274(9)

0.0298(9)

-0.0173(7)

0.0072(7)

-0.0103(7)

C9

0.0282(9)

0.0294(9)

0.0348(10)

-0.0196(8)

0.0052(7)

-0.0154(8)

C10

0.0225(8)

0.0247(8)

0.0258(8)

-0.0093(7)

0.0029(7)

-0.0140(7)

C11

0.0166(7)

0.0201(7)

0.0180(7)

-0.0060(6)

0.0025(6)

-0.0083(6)

C14

0.0156(7)

0.0212(8)

0.0218(8)

-0.0071(6)

0.0015(6)

-0.0071(6)

C15

0.0196(8)

0.0190(8)

0.0309(9)

-0.0071(7)

0.0000(7)

-0.0032(6)

C16

0.0274(9)

0.0174(8)

0.0291(9)

-0.0017(7)

-0.0009(7)

-0.0085(7)

C17

0.0221(8)

0.0221(8)

0.0225(8)

-0.0044(7)

0.0028(6)

-0.0113(7)

C18

0.0160(7)

0.0194(7)

0.0167(7)

-0.0068(6)

0.0013(6)

-0.0086(6)

C19

0.0172(7)

0.0184(7)

0.0159(7)

-0.0074(6)

0.0019(6)

-0.0090(6)
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C20

0.0238(8)

0.0232(8)

0.0183(8)

-0.0077(6)

0.0056(6)

-0.0133(7)

C21

0.0216(8)

0.0295(9)

0.0246(8)

-0.0140(7)

0.0104(7)

-0.0126(7)

C22

0.0197(8)

0.0251(8)

0.0266(9)

-0.0131(7)

0.0069(7)

-0.0056(7)

C23

0.0189(8)

0.0198(8)

0.0201(8)

-0.0076(6)

0.0034(6)

-0.0064(6)

C26

0.0164(7)

0.0174(7)

0.0169(7)

-0.0052(6)

0.0029(6)

-0.0061(6)

C27

0.0222(8)

0.0189(8)

0.0203(8)

-0.0082(6)

0.0042(6)

-0.0083(6)

C28

0.0236(8)

0.0224(8)

0.0218(8)

-0.0097(6)

0.0009(6)

-0.0112(7)

C29

0.0173(7)

0.0211(8)

0.0202(8)

-0.0051(6)

-0.0007(6)

-0.0076(6)

C30

0.0162(7)

0.0167(7)

0.0178(7)

-0.0052(6)

0.0025(6)

-0.0062(6)

C31

0.0268(9)

0.0264(9)

0.0281(9)

-0.0135(7)

0.0001(7)

-0.0087(7)

C32

0.0350(11)

0.0292(10)

0.0446(12)

-0.0212(9)

-0.0036(9)

-0.0021(8)

C34

0.0151(7)

0.0194(7)

0.0174(7)

-0.0088(6)

0.0038(6)

-0.0075(6)

C35

0.0196(7)

0.0177(7)

0.0166(7)

-0.0082(6)

0.0067(6)

-0.0080(6)

C36

0.0200(8)

0.0171(7)

0.0172(7)

-0.0053(6)

0.0021(6)

-0.0042(6)

C37

0.0161(7)

0.0211(8)

0.0207(8)

-0.0088(6)

0.0009(6)

-0.0060(6)

C38

0.0153(7)

0.0188(7)

0.0210(8)

-0.0089(6)

0.0033(6)

-0.0082(6)

C39

0.0209(8)

0.0196(8)

0.0193(8)

-0.0077(6)

0.0049(6)

-0.0068(6)

C40

0.0298(9)

0.0251(9)

0.0268(9)

-0.0100(7)

0.0096(7)

-0.0149(7)

P1

0.01575(19)

0.0244(2)

0.0210(2)

-0.01088(17)

0.00422(15)

-0.00833(16)

F1

0.0199(5)

0.0419(7)

0.0526(7)

-0.0303(6)

0.0009(5)

-0.0113(5)

F2

0.0166(5)

0.0530(8)

0.0643(9)

-0.0304(7)

-0.0008(5)

-0.0103(5)

F3

0.0471(8)

0.0362(7)

0.0502(8)

0.0053(6)

0.0052(6)

-0.0149(6)

F4

0.0363(7)

0.0536(8)

0.0534(8)

-0.0411(7)

0.0134(6)

-0.0111(6)

F5

0.0426(7)

0.0355(7)

0.0405(7)

-0.0020(5)

0.0113(6)

-0.0151(6)

F6

0.0305(6)

0.0582(8)

0.0378(6)

-0.0358(6)

0.0084(5)

-0.0177(6)
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P2

0.01733(19)

0.0287(2)

0.0218(2)

-0.01123(17)

0.00414(16)

-0.01182(17)

F7

0.1081(13)

0.0372(7)

0.0286(7)

-0.0170(6)

0.0303(7)

-0.0324(8)

F8

0.1137(14)

0.0909(12)

0.0411(8)

-0.0449(8)

0.0397(9)

-0.0807(12)

F9

0.0283(7)

0.0710(10)

0.0773(11)

0.0349(9)

-0.0177(7)

-0.0329(7)

F10

0.0297(6)

0.0302(6)

0.0310(6)

-0.0061(5)

0.0064(5)

-0.0148(5)

F11

0.0200(6)

0.0354(7)

0.0984(12)

-0.0064(7)

-0.0155(7)

-0.0078(5)

F12

0.0438(7)

0.0322(6)

0.0451(7)

-0.0163(5)

0.0065(6)

-0.0221(5)

C41

0.0405(11)

0.0273(9)

0.0309(10)

-0.0136(8)

-0.0054(8)

-0.0148(8)

C42

0.0437(13)

0.0595(16)

0.0807(19)

-0.0376(15)

0.0061(13)

-0.0310(12)

C43

0.0648(15)

0.0345(11)

0.0319(11)

-0.0191(9)

0.0104(10)

-0.0216(11)

O1

0.0649(12)

0.0273(8)

0.0487(10)

-0.0093(7)

C44

0.030(2)

0.035(2)

0.0234(18)

-0.0038(16)

0.0006(17)

-0.0205(18)

C45

0.033(2)

0.056(3)

0.047(2)

-0.0104(19)

-0.0049(18)

-0.0172(19)

C46

0.052(3)

0.039(3)

0.051(3)

-0.018(3)

0.016(3)

-0.029(3)

O2

0.0426(15)

0.0430(15)

0.0558(17)

-0.0174(13)

0.0019(12)

-0.0259(12)

C47

0.030(2)

0.024(2)

0.025(2)

0.0034(18)

0.0004(19)

-0.019(2)

C48

0.038(4)

0.042(4)

0.030(3)

0.003(3)

-0.011(3)

-0.013(3)

C49

0.062(6)

0.052(5)

0.042(4)

-0.021(4)

-0.008(5)

-0.018(4)

O3

0.0254(16)

0.0274(16)

0.0234(15)

-0.0020(13)

-0.0050(12)

-0.0114(13)

C50

0.0300(16)

0.0191(14)

0.0274(16)

-0.0095(14)

0.0036(14)

-0.0020(11)

C51

0.065(3)

0.041(2)

0.028(2)

-0.0137(18)

0.014(2)

-0.028(2)

C52

0.046(3)

0.032(2)

0.040(3)

-0.010(2)

-0.010(3)

-0.013(2)

O4

0.0321(15)

0.0307(14)

0.0386(16)

-0.0121(12)

form

of

the

anisotropic

-0.0069(8)

0.0000(12)

displacement

exp[-22(a*2U11h2+b*2U22k2+c*2U33l2+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)]
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-0.0086(8)

-0.0082(12)

parameter

is:

Table A1-5. Bond distances in [RuBEP](PF6)2, Å
Ru1-N13

2.0595(13)

Ru1-N12

2.0617(13)

Ru1-N24

2.0660(13)

Ru1-N1

2.0750(13)

Ru1-N33

2.0981(13)

Ru1-N25

2.1083(13)

N1-C2

1.345(2)

N1-C6

1.359(2)

N12-C11

1.344(2)

N12-C7

1.362(2)

N13-C14

1.345(2)

N13-C18

1.363(2)

N24-C23

1.345(2)

N24-C19

1.362(2)

N25-C26

1.349(2)

N25-C30

1.355(2)

N33-C34

1.346(2)

N33-C38

1.354(2)

C2-C3

1.384(2)

C3-C4

1.384(3)

C4-C5

1.388(2)

C5-C6

1.391(2)

C6-C7

1.476(2)

C7-C8

1.390(2)

C8-C9

1.384(2)

C9-C10

1.381(3)

C10-C11

1.382(2)

C14-C15

1.383(2)

C15-C16

1.387(3)

C16-C17

1.380(2)

C17-C18

1.392(2)

C18-C19

1.471(2)

C19-C20

1.388(2)

C20-C21

1.384(2)

C21-C22

1.384(3)

C22-C23

1.386(2)

C26-C27

1.398(2)

C27-C28

1.395(2)

C27-C31

1.438(2)

C28-C29

1.386(2)

C29-C30

1.383(2)

C31-C32

1.182(3)

C34-C35

1.397(2)

C35-C36

1.391(2)

C35-C39

1.439(2)

C36-C37

1.385(2)

C37-C38

1.383(2)

C39-C40

1.187(3)

P1-F3

1.5831(13)

P1-F4

1.5904(12)

P1-F6

1.5956(11)

P1-F2

1.5998(12)

P1-F5

1.6021(13)

P1-F1

1.6064(11)

P2-F11

1.5717(13)

P2-F8

1.5821(14)

P2-F7

1.5907(13)

P2-F12

1.5967(12)

P2-F9

1.5980(13)

P2-F10

1.6070(12)

C41-O1

1.207(3)

C41-C43

1.488(3)

C41-C42

1.498(3)

C44-O2

1.205(4)

C44-C45

1.490(5)

C44-C46

1.504(6)

C47-O3

1.217(5)

C47-C49

1.499(7)

C47-C48

1.506(6)

C50-O4

1.192(5)

C50-C51

1.509(5)

C50-C52

1.538(6)

208

Table A1-6. Bond angles in [RuBEP](PF6)2, °
N13-Ru1-N12

83.17(5)

N13-Ru1-N24

78.73(5)

N12-Ru1-N24

96.51(5)

N13-Ru1-N1

97.01(5)

N12-Ru1-N1

78.84(5)

N24-Ru1-N1

174.11(5)

N13-Ru1-N33

172.47(5)

N12-Ru1-N33

91.25(5)

N24-Ru1-N33

96.99(5)

N1-Ru1-N33

86.80(5)

N13-Ru1-N25

93.45(5)

N12-Ru1-N25

174.24(5)

N24-Ru1-N25

87.36(5)

N1-Ru1-N25

97.01(5)

N33-Ru1-N25

92.52(5)

C2-N1-C6

118.06(13)

C2-N1-Ru1

126.69(11)

C6-N1-Ru1

115.21(10)

C11-N12-C7

118.18(14)

C11-N12-Ru1

125.44(11)

C7-N12-Ru1

115.65(10)

C14-N13-C18

118.04(14)

C14-N13-Ru1

125.13(11)

C18-N13-Ru1

115.42(10)

C23-N24-C19

117.88(13)

C23-N24-Ru1

126.67(11)

C19-N24-Ru1

115.45(10)

C26-N25-C30

117.15(14)

C26-N25-Ru1

123.00(11)

C30-N25-Ru1

119.83(10)

C34-N33-C38

117.45(14)

C34-N33-Ru1

122.42(11)

C38-N33-Ru1

120.04(10)

N1-C2-C3

123.04(15)

C2-C3-C4

118.81(15)

C3-C4-C5

119.01(15)

C4-C5-C6

119.28(16)

N1-C6-C5

121.77(15)

N1-C6-C7

115.09(14)

C5-C6-C7

123.14(15)

N12-C7-C8

121.53(15)

N12-C7-C6

114.77(14)

C8-C7-C6

123.64(15)

C9-C8-C7

119.35(16)

C10-C9-C8

119.12(16)

C9-C10-C11

118.91(16)

N12-C11-C10

122.89(15)

N13-C14-C15

122.82(15)

C14-C15-C16

119.12(16)

C17-C16-C15

118.79(16)

C16-C17-C18

119.60(16)

N13-C18-C17

121.61(15)

N13-C18-C19

114.62(14)

C17-C18-C19

123.71(14)

N24-C19-C20

121.75(15)

N24-C19-C18

114.87(13)

C20-C19-C18

123.38(15)

C21-C20-C19

119.82(16)

C22-C21-C20

118.42(15)

C21-C22-C23

119.33(16)

N24-C23-C22

122.79(16)

N25-C26-C27

123.01(15)

C28-C27-C26

118.87(15)

C28-C27-C31

121.66(16)

C26-C27-C31

119.46(15)

C29-C28-C27

118.30(15)

C30-C29-C28

119.51(15)

N25-C30-C29

123.16(15)

C32-C31-C27

178.6(2)

N33-C34-C35

122.86(15)

C36-C35-C34

118.75(15)

C36-C35-C39

121.81(15)
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C34-C35-C39

119.44(15)

C37-C36-C35

118.71(15)

C38-C37-C36

119.18(15)

N33-C38-C37

123.05(15)

C40-C39-C35

178.65(18)

F3-P1-F4

90.54(8)

F3-P1-F6

90.85(8)

F4-P1-F6

178.55(8)

F3-P1-F2

91.13(8)

F4-P1-F2

90.12(7)

F6-P1-F2

90.26(7)

F3-P1-F5

178.94(8)

F4-P1-F5

89.28(8)

F6-P1-F5

89.32(7)

F2-P1-F5

89.91(8)

F3-P1-F1

89.77(8)

F4-P1-F1

90.64(7)

F6-P1-F1

88.97(6)

F2-P1-F1

178.82(7)

F5-P1-F1

89.19(7)

F11-P2-F8

91.44(10)

F11-P2-F7

91.11(10)

F8-P2-F7

177.15(11)

F11-P2-F12

91.15(7)

F8-P2-F12

91.85(8)

F7-P2-F12

89.35(7)

F11-P2-F9

178.68(9)

F8-P2-F9

88.88(11)

F7-P2-F9

88.54(10)

F12-P2-F9

90.12(8)

F11-P2-F10

88.99(7)

F8-P2-F10

89.09(7)

F7-P2-F10

89.69(7)

F12-P2-F10

179.04(7)

F9-P2-F10

89.74(7)

O1-C41-C43

122.0(2)

O1-C41-C42

121.9(2)

C43-C41-C42

116.0(2)

O2-C44-C45

121.9(4)

O2-C44-C46

120.7(4)

C45-C44-C46

117.4(4)

O3-C47-C49

121.7(5)

O3-C47-C48

120.6(5)

C49-C47-C48

117.7(5)

O4-C50-C51

121.7(4)

O4-C50-C52

120.6(5)

C51-C50-C52

117.7(5)
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Appendix B. Table of Abbreviations
Abbreviation

Definition

[Ru(bpy)2XY]n+

Ru(II) center with two bipyridines and two monodentate ligands

1-P

1-photon

2′-F RNA

2′-Fluoro RNA

2′-OMe RNA

2′-O-methyl RNA

2-P

2-photon

3-EP

3-ethynylpyridine ligand

4-AP

4-aminopyridine

6-FAM

carboxyfluorescein

BHQ1

black hole quencher

bpy

2, 2′-bipyridine

CHANT1

caged hairpin antagomir with 1 photocleavable moiety, targeting let-7

CHANT2

caged hairpin antagomir with 2 photocleavable moieties, targeting let-7

chd

zebrafish chordin gene

chd-MO

control morpholino targeting chordin

CIRClet7

circular let-7 miRNA

CLSM

confocal laser scanning microscopy

DLS

dynamic light scattering

DMNPE

(dimethoxy-2-nitrophenyl)ethyl moiety
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DMT

dimethoxytrityl

FITC

fluorescein isothiocyanate

fl-MO

fluorescein labeled morpholino

GM

Göppert-Mayer

hpf

hours post fertilization

ISC

intersystem crossing

let-7

zebrafish miRNA, lethal-7

LF

ligand field

LNA

locked nucleic acid

MB

molecular beacon

miRNA

micro RNA

MLCT

metal to ligand charge transfer

MO

morpholino

N3-DNA

DNA with single azide modification

N3-DNA-N3

DNA with two azide modifications

ntl

zebrafish notail gene

ntl-MO

control morpholino targeting notail

OB29

polyethyleneoxide30 - polybutadiene46

ONB

o-nitrobenzyl photocleavable moiety

PAGE

polyacrylamide gel electrophoresis
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PL

nitrobenzyl photocleavable linker moiety

PZn2

meso to meso ethyne bridged [bis(porphinato)zinc]

RISC

RNA-induced silencing complex

RNAi

RNA interference

RuBEP

Ru(bpy)2(3-ethynylpyridine)2Cl2

Ru-cDNA

DNA circularized with RuBEP

Ru-DNA

DNA singly clicked to RuBEP

Ru-cMO

Morpholino circularized with RuBEP

siRNA

short interfering RNA

Sulfo-EMCS

N-Ɛ-Maleimidocaproyl-oxysulfosuccinimide ester

TBTA

([(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine)

TEAA

triethylammonium acetate

TLF wildtype

Tuebingen long fin wildtype zebrafish

Tu wildtype

Tuebingen wildtype zebrafish

WT

wildtype

213

